Go to the Table of Contents
140320
Table 1.47A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 16,563 17,129 573 575 182 269
GENDER            
Male 11,460 11,467 490 444 171 201
Female 5,104 5,661 83 130 11a 68
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15,224 15,526 440 527 162 249
White 14,015 14,184 341 482 119 211
Black or African American 600 498 20 19 20 14
American Indian or Alaska Native 97 100 10 1 * *
Native Hawaiian or Other Pacific Islander 15 * 2 * * *
Asian 313 183 49 23 8 23
Two or More Races 184b 486 17 2 9 *
Hispanic or Latino 1,340 1,603 133 48 20 21
EDUCATION            
< High School 1,847a 1,411 32 34 24 19
High School Graduate 3,999 4,064 98 110 10a 67
Some College 4,389a 5,277 116 142 57 72
College Graduate 6,329 6,377 328 289 91 111
CURRENT EMPLOYMENT            
Full-Time 10,412 10,746 383 385 105 175
Part-Time 2,145 2,397 56 63 26 43
Unemployed 1,000 887 69 44 * *
Other1 3,007 3,100 65 83 14 51
140320
Table 1.47B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 8.3 8.4 0.3 0.3 0.1 0.1
GENDER            
Male 12.0 11.8 0.5 0.5 0.2 0.2
Female 4.9 5.4 0.1 0.1 0.0a 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8.8 8.9 0.3 0.3 0.1 0.1
White 10.3 10.4 0.3 0.4 0.1 0.2
Black or African American 2.7 2.2 0.1 0.1 0.1 0.1
American Indian or Alaska Native 9.5 9.9 1.0 0.1 * *
Native Hawaiian or Other Pacific Islander 1.9 * 0.3 * * *
Asian 3.2 1.8 0.5 0.2 0.1 0.2
Two or More Races 6.9b 17.3 0.7 0.1 0.3 *
Hispanic or Latino 4.8 5.6 0.5 0.2 0.1 0.1
EDUCATION            
< High School 6.4 5.3 0.1 0.1 0.1 0.1
High School Graduate 6.9 7.0 0.2 0.2 0.0a 0.1
Some College 8.7a 10.3 0.2 0.3 0.1 0.1
College Graduate 10.0 9.5 0.5 0.4 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 10.0 10.2 0.4 0.4 0.1 0.2
Part-Time 9.2 10.0 0.2 0.3 0.1 0.2
Unemployed 10.6 11.6 0.7 0.6 * *
Other1 4.7 4.7 0.1 0.1 0.0 0.1
140320
Table 1.48A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 19,482 19,741 1,046 1,053 305 375
GENDER            
Male 13,204 12,992 780 788 249 284
Female 6,278 6,749 265 265 55 92
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 17,629 17,621 844 901 266 340
White 16,019 15,941 674 787 194 278
Black or African American 771 661 67 51 41 25
American Indian or Alaska Native 135 121 12 3 * 1
Native Hawaiian or Other Pacific Islander 36 * 2 * * *
Asian 395 263 54 36 9 27
Two or More Races 273a 553 33 24 16 8
Hispanic or Latino 1,853 2,120 202 152 38 35
EDUCATION            
< High School 2,344a 1,864 132 89 51 31
High School Graduate 5,008 4,985 266 300 52 107
Some College 5,441 6,156 279 302 100 111
College Graduate 6,689 6,737 370 362 101 125
CURRENT EMPLOYMENT            
Full-Time 11,593 11,819 539 524 141 210
Part-Time 2,990 3,104 231 211 84 74
Unemployed 1,371 1,278 119 148 45 27
Other1 3,528 3,541 156 169 34 65
140320
Table 1.48B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 8.3 8.3 0.4 0.4 0.1 0.2
GENDER            
Male 11.7 11.4 0.7 0.7 0.2 0.2
Female 5.1 5.5 0.2 0.2 0.0 0.1
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8.8 8.7 0.4 0.4 0.1 0.2
White 10.3 10.2 0.4 0.5 0.1 0.2
Black or African American 2.8 2.4 0.2 0.2 0.2 0.1
American Indian or Alaska Native 10.4 9.8 0.9 0.3 * 0.1
Native Hawaiian or Other Pacific Islander 3.7 * 0.2 * * *
Asian 3.4 2.2 0.5 0.3 0.1 0.2
Two or More Races 8.0b 15.6 1.0 0.7 0.5 0.2
Hispanic or Latino 5.3 5.9 0.6 0.4 0.1 0.1
EDUCATION            
< High School 6.8 5.8 0.4 0.3 0.2 0.1
High School Graduate 7.2 7.1 0.4 0.4 0.1 0.2
Some College 8.7 9.7 0.4 0.5 0.2 0.2
College Graduate 9.8 9.4 0.5 0.5 0.1 0.2
CURRENT EMPLOYMENT            
Full-Time 9.9 9.9 0.5 0.4 0.1 0.2
Part-Time 9.1 9.2 0.7 0.6 0.3 0.2
Unemployed 10.1 10.8 0.9 1.3 0.3 0.2
Other1 5.0 4.9 0.2 0.2 0.0 0.1
140320
Table 1.49A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 54,389 53,172 16,666a 15,348 6,831 6,484
AGE            
12-17 2,482b 2,188 1,642b 1,441 693b 549
18-25 9,709a 9,239 4,729b 4,245 1,832 1,661
26 or Older 42,198 41,745 10,296 9,662 4,306 4,274
GENDER            
Male 29,080a 27,490 8,663a 7,772 3,565 3,340
Female 25,309 25,682 8,003 7,576 3,266 3,144
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 46,859 46,329 13,970a 12,783 5,845 5,295
White 39,534 39,412 11,296 10,527 4,790 4,325
Black or African American 4,497 4,128 1,810a 1,377 720 716
American Indian or Alaska Native 419 344 158 139 67 29
Native Hawaiian or Other Pacific Islander 204 212 44 43 14 10
Asian 1,219 1,110 376 313 154 110
Two or More Races 987 1,124 286 384 99 106
Hispanic or Latino 7,530 6,843 2,696 2,565 985 1,189
140320
Table 1.49B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 20.9 20.3 6.4a 5.8 2.6 2.5
AGE            
12-17 10.0b 8.8 6.6b 5.8 2.8b 2.2
18-25 28.1a 26.6 13.7b 12.2 5.3 4.8
26 or Older 21.0 20.6 5.1 4.8 2.1 2.1
GENDER            
Male 23.1a 21.6 6.9a 6.1 2.8 2.6
Female 18.9 19.0 6.0 5.6 2.4 2.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.3 21.0 6.4a 5.8 2.7 2.4
White 23.3 23.2 6.7 6.2 2.8 2.5
Black or African American 14.6 13.2 5.9b 4.4 2.3 2.3
American Indian or Alaska Native 29.0 24.5 10.9 9.9 4.7 2.1
Native Hawaiian or Other Pacific Islander 18.9 24.4 4.1 5.0 1.3 1.1
Asian 9.5 8.3 2.9 2.3 1.2 0.8
Two or More Races 23.8 26.2 6.9 9.0 2.4 2.5
Hispanic or Latino 18.7a 16.6 6.7 6.2 2.4 2.9
140320
Table 1.50A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 2,482b 2,188 1,642b 1,441 693b 549
GENDER            
Male 1,209 1,105 777 728 308 257
Female 1,273b 1,083 865b 713 385b 292
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,938b 1,700 1,315b 1,131 558b 429
White 1,390a 1,214 965a 834 406b 293
Black or African American 362 306 240 188 104 102
American Indian or Alaska Native 19 23 11 18 7 3
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 49 48 24 22 12 5
Two or More Races 97 91 68 55 28 19
Hispanic or Latino 544 488 327 310 135 120
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 669 615 451 425 186 146
Female, White, Not Hispanic 722a 599 514b 409 220b 147
Male, Black, Not Hispanic 178 147 111 85 34 49
Female, Black, Not Hispanic 184 159 129 103 70 54
Male, Hispanic 265 247 166 157 66 48
Female, Hispanic 279 241 161 153 69 71
140320
Table 1.50B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 10.0b 8.8 6.6b 5.8 2.8b 2.2
GENDER            
Male 9.5 8.7 6.1 5.7 2.4 2.0
Female 10.4b 8.9 7.1b 5.9 3.2b 2.4
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 10.0b 8.8 6.8b 5.9 2.9b 2.2
White 10.1b 8.9 7.0a 6.1 3.0b 2.2
Black or African American 10.3 8.9 6.8 5.5 3.0 3.0
American Indian or Alaska Native 12.8 14.2 7.4 11.2 4.7 1.9
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 4.2 3.9 2.0 1.7 1.0 0.4
Two or More Races 13.2 12.0 9.3 7.2 3.8 2.5
Hispanic or Latino 9.9 8.8 5.9 5.6 2.5 2.1
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 9.5 8.8 6.4 6.1 2.6 2.1
Female, White, Not Hispanic 10.8b 9.0 7.7b 6.1 3.3b 2.2
Male, Black, Not Hispanic 10.0 8.4 6.2 4.9 1.9 2.8
Female, Black, Not Hispanic 10.6 9.4 7.4 6.1 4.0 3.2
Male, Hispanic 9.4 8.7 5.9 5.5 2.4 1.7
Female, Hispanic 10.4 8.8 6.0 5.6 2.6 2.6
140320
Table 1.51A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 9,709a 9,239 4,729b 4,245 1,832 1,661
GENDER            
Male 5,093 4,958 2,517 2,358 917 884
Female 4,616a 4,280 2,212b 1,886 915a 777
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8,083b 7,605 4,013b 3,534 1,548 1,398
White 6,541a 6,108 3,195a 2,864 1,241 1,109
Black or African American 884 912 475 408 186 194
American Indian or Alaska Native * 64 * 28 12 17
Native Hawaiian or Other Pacific Islander * 41 14 16 7 2
Asian 242 255 127 113 58 41
Two or More Races 282 224 131 105 43 36
Hispanic or Latino 1,626 1,634 716 711 285 263
EDUCATION            
< High School 1,603 1,585 803 710 325 331
High School Graduate 3,194 3,107 1,622 1,432 693a 571
Some College 3,493 3,210 1,703 1,508 644 535
College Graduate 1,419 1,337 600 596 171 224
CURRENT EMPLOYMENT            
Full-Time 4,106 3,877 1,796 1,621 729 649
Part-Time 2,622 2,489 1,281 1,274 457 454
Unemployed 1,282 1,230 726a 606 328 263
Other1 1,699 1,643 926a 743 318 295
140320
Table 1.51B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 28.1a 26.6 13.7b 12.2 5.3 4.8
GENDER            
Male 29.4 28.4 14.5 13.5 5.3 5.1
Female 26.8a 24.7 12.8b 10.9 5.3a 4.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 29.4b 27.6 14.6b 12.8 5.6 5.1
White 33.5b 31.3 16.3b 14.7 6.4 5.7
Black or African American 18.0 18.2 9.7 8.2 3.8 3.9
American Indian or Alaska Native * 27.6 * 12.2 4.5 7.2
Native Hawaiian or Other Pacific Islander * 20.6 7.4 7.8 3.9 0.9
Asian 13.6 13.7 7.1 6.0 3.2 2.2
Two or More Races 37.1 30.6 17.2 14.4 5.7 4.9
Hispanic or Latino 22.8 22.5 10.0 9.8 4.0 3.6
EDUCATION            
< High School 30.1 28.4 15.1a 12.7 6.1 5.9
High School Graduate 27.1 26.0 13.8a 12.0 5.9a 4.8
Some College 28.3 26.4 13.8 12.4 5.2 4.4
College Graduate 27.7 26.5 11.7 11.8 3.3 4.4
CURRENT EMPLOYMENT            
Full-Time 30.5 28.7 13.3 12.0 5.4 4.8
Part-Time 27.9 25.7 13.6 13.2 4.9 4.7
Unemployed 31.2 29.6 17.7a 14.6 8.0 6.3
Other1 22.3 22.1 12.2a 10.0 4.2 4.0
140320
Table 1.52A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 42,198 41,745 10,296 9,662 4,306 4,274
GENDER            
Male 22,778 21,427 5,369 4,686 2,340 2,200
Female 19,420 20,318 4,927 4,976 1,966 2,075
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 36,839 37,024 8,642 8,118 3,740 3,468
White 31,602 32,089 7,136 6,829 3,143 2,923
Black or African American 3,250 2,910 1,095 781 430 419
American Indian or Alaska Native 303 257 76 93 48 9
Native Hawaiian or Other Pacific Islander * * 23 12 6 1
Asian 928 806 225 179 85 64
Two or More Races 608 809 87a 224 28 51
Hispanic or Latino 5,360 4,721 1,654 1,544 566 807
EDUCATION            
< High School 5,419b 4,284 1,650 1,378 647 827
High School Graduate 11,204 10,639 2,907 2,591 1,295 1,252
Some College 12,103 12,617 3,076 2,902 1,143 1,209
College Graduate 13,473 14,205 2,662 2,791 1,220 986
CURRENT EMPLOYMENT            
Full-Time 25,595a 23,833 6,039a 5,068 2,410 1,978
Part-Time 5,090a 6,264 1,250 1,477 611 668
Unemployed 2,765a 2,145 864 780 478 385
Other1 8,748 9,504 2,143 2,338 807a 1,244
140320
Table 1.52B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 21.0 20.6 5.1 4.8 2.1 2.1
GENDER            
Male 23.8a 22.1 5.6a 4.8 2.4 2.3
Female 18.5 19.2 4.7 4.7 1.9 2.0
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 21.3 21.2 5.0 4.7 2.2 2.0
White 23.2 23.4 5.2 5.0 2.3 2.1
Black or African American 14.6 12.8 4.9a 3.4 1.9 1.8
American Indian or Alaska Native 29.4 25.4 7.4 9.2 4.7 0.9
Native Hawaiian or Other Pacific Islander * * 2.9 2.2 0.8 0.2
Asian 9.4 7.9 2.3 1.7 0.9 0.6
Two or More Races 22.9 28.8 3.3a 8.0 1.1 1.8
Hispanic or Latino 19.4 16.6 6.0 5.4 2.0 2.8
EDUCATION            
< High School 18.7 16.1 5.7 5.2 2.2 3.1
High School Graduate 19.3 18.3 5.0 4.5 2.2 2.2
Some College 24.1 24.6 6.1 5.7 2.3 2.4
College Graduate 21.2 21.2 4.2 4.2 1.9 1.5
CURRENT EMPLOYMENT            
Full-Time 24.6b 22.6 5.8b 4.8 2.3a 1.9
Part-Time 21.8b 26.0 5.3 6.1 2.6 2.8
Unemployed 29.2 28.0 9.1 10.2 5.0 5.0
Other1 13.8 14.5 3.4 3.6 1.3a 1.9
140320
Table 1.53A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 51,908 50,984 15,025 13,907 6,138 5,935
GENDER            
Male 27,872a 26,385 7,886a 7,044 3,257 3,083
Female 24,036 24,599 7,139 6,862 2,881 2,852
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 44,922 44,629 12,655a 11,652 5,288 4,866
White 38,144 38,198 10,331 9,693 4,384 4,032
Black or African American 4,134 3,823 1,569a 1,189 616 613
American Indian or Alaska Native 400 321 147 121 60 26
Native Hawaiian or Other Pacific Islander * * 37 28 13 3
Asian 1,169 1,061 352 292 142 105
Two or More Races 890 1,033 218 330 72 87
Hispanic or Latino 6,986 6,355 2,370 2,254 850 1,070
EDUCATION            
< High School 7,022b 5,869 2,454 2,088 972 1,158
High School Graduate 14,398 13,745 4,530 4,023 1,988 1,823
Some College 15,596 15,827 4,779 4,409 1,787 1,744
College Graduate 14,892 15,543 3,262 3,386 1,391 1,210
CURRENT EMPLOYMENT            
Full-Time 29,701a 27,710 7,834b 6,689 3,140a 2,627
Part-Time 7,712a 8,753 2,531 2,751 1,067 1,122
Unemployed 4,047a 3,374 1,590 1,386 806 647
Other1 10,447 11,147 3,069 3,081 1,125a 1,539
140320
Table 1.53B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 22.1 21.5 6.4a 5.9 2.6 2.5
GENDER            
Male 24.6a 23.1 7.0a 6.2 2.9 2.7
Female 19.7 20.0 5.9 5.6 2.4 2.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 22.4 22.1 6.3a 5.8 2.6 2.4
White 24.5 24.4 6.6 6.2 2.8 2.6
Black or African American 15.2 13.8 5.8a 4.3 2.3 2.2
American Indian or Alaska Native 30.9 25.8 11.3 9.7 4.7 2.1
Native Hawaiian or Other Pacific Islander * * 3.7 3.6 1.4 0.4
Asian 10.1 8.8 3.0 2.4 1.2 0.9
Two or More Races 26.0 29.2 6.4 9.3 2.1 2.5
Hispanic or Latino 20.1 17.8 6.8 6.3 2.4 3.0
EDUCATION            
< High School 20.5a 18.2 7.2 6.5 2.8 3.6
High School Graduate 20.7 19.6 6.5 5.7 2.9 2.6
Some College 24.9 25.0 7.6 7.0 2.9 2.8
College Graduate 21.7 21.6 4.8 4.7 2.0 1.7
CURRENT EMPLOYMENT            
Full-Time 25.2b 23.3 6.7b 5.6 2.7a 2.2
Part-Time 23.5a 25.9 7.7 8.2 3.3 3.3
Unemployed 29.8 28.6 11.7 11.7 5.9 5.5
Other1 14.7 15.3 4.3 4.2 1.6a 2.1
140320
Table 1.54A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 37,045 35,473 12,489b 11,082 4,862 4,521
AGE            
12-17 2,069b 1,805 1,333b 1,157 558b 425
18-25 7,759b 7,251 3,507b 3,061 1,311a 1,132
26 or Older 27,218 26,417 7,649 6,865 2,993 2,964
GENDER            
Male 20,826b 18,918 6,851b 5,834 2,646 2,398
Female 16,219 16,555 5,638 5,248 2,216 2,123
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 31,771 30,514 10,439b 9,223 4,179 3,733
White 26,237 25,502 8,181a 7,380 3,306 2,968
Black or African American 3,587a 3,108 1,599b 1,120 615 573
American Indian or Alaska Native 266 230 113 97 56 19
Native Hawaiian or Other Pacific Islander * 177 33 34 4 9
Asian 809 716 294 244 116 74
Two or More Races 711 780 218 349 82 90
Hispanic or Latino 5,274 4,959 2,051 1,859 683 788
140320
Table 1.54B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.2a 13.5 4.8b 4.2 1.9 1.7
AGE            
12-17 8.3b 7.3 5.3b 4.6 2.2b 1.7
18-25 22.4b 20.8 10.1b 8.8 3.8a 3.3
26 or Older 13.6 13.0 3.8 3.4 1.5 1.5
GENDER            
Male 16.5b 14.9 5.4b 4.6 2.1 1.9
Female 12.1 12.2 4.2 3.9 1.7 1.6
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 14.5 13.8 4.8b 4.2 1.9 1.7
White 15.5 15.0 4.8a 4.3 1.9 1.7
Black or African American 11.7a 10.0 5.2b 3.6 2.0 1.8
American Indian or Alaska Native 18.4 16.4 7.8 6.9 3.9 1.4
Native Hawaiian or Other Pacific Islander * 20.4 3.1 3.9 0.4 1.1
Asian 6.3 5.4 2.3 1.8 0.9 0.6
Two or More Races 17.1 18.2 5.3 8.1 2.0 2.1
Hispanic or Latino 13.1 12.0 5.1 4.5 1.7 1.9
140320
Table 1.55A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 2,069b 1,805 1,333b 1,157 558b 425
GENDER            
Male 1,029a 902 653 575 250a 189
Female 1,040a 904 680a 582 308a 236
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 1,612b 1,410 1,053a 916 445b 332
White 1,136a 988 754 664 317b 220
Black or African American 324 268 212a 160 89 86
American Indian or Alaska Native 17 20 8 16 4 3
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 35 37 17 18 9 3
Two or More Races 85 79 55 46 25 14
Hispanic or Latino 456 395 280 241 113 93
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 562 511 368 340 151 109
Female, White, Not Hispanic 575a 477 386 324 166b 111
Male, Black, Not Hispanic 160 125 102a 65 29 37
Female, Black, Not Hispanic 165 143 110 94 59 49
Male, Hispanic 226 184 140 114 54 34
Female, Hispanic 230 211 140 126 60 59
140320
Table 1.55B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 8.3b 7.3 5.3b 4.6 2.2b 1.7
GENDER            
Male 8.1a 7.1 5.1 4.5 2.0a 1.5
Female 8.5a 7.4 5.6a 4.8 2.5a 1.9
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 8.3b 7.3 5.4a 4.7 2.3b 1.7
White 8.3a 7.2 5.5 4.9 2.3b 1.6
Black or African American 9.2 7.8 6.0 4.6 2.5 2.5
American Indian or Alaska Native 11.5 12.6 5.3 9.9 3.0 1.9
Native Hawaiian or Other Pacific Islander * * * * * *
Asian 3.0 3.0 1.4 1.4 0.8 0.3
Two or More Races 11.6 10.5 7.6 6.1 3.4 1.8
Hispanic or Latino 8.3 7.1 5.1 4.3 2.1 1.7
GENDER/RACE/HISPANIC ORIGIN            
Male, White, Not Hispanic 8.0 7.3 5.2 4.9 2.1 1.6
Female, White, Not Hispanic 8.6a 7.1 5.8 4.9 2.5b 1.7
Male, Black, Not Hispanic 8.9 7.1 5.7a 3.7 1.6 2.1
Female, Black, Not Hispanic 9.5 8.5 6.3 5.6 3.4 2.9
Male, Hispanic 8.1 6.5 5.0 4.0 1.9 1.2
Female, Hispanic 8.6 7.8 5.2 4.6 2.2 2.2
140320
Table 1.56A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 7,759b 7,251 3,507b 3,061 1,311a 1,132
GENDER            
Male 4,245 4,020 1,898 1,759 685 631
Female 3,514a 3,231 1,609b 1,302 626a 501
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 6,499b 5,973 2,994b 2,533 1,114a 941
White 5,173a 4,743 2,345b 1,997 860a 710
Black or African American 796 770 412 335 162 160
American Indian or Alaska Native 57 56 33 24 10 13
Native Hawaiian or Other Pacific Islander * 35 9 15 2 1
Asian 182 170 100 71 46 29
Two or More Races 261 198 96 91 33 27
Hispanic or Latino 1,259 1,278 513 527 197 191
EDUCATION            
< High School 1,354 1,311 625 565 258 237
High School Graduate 2,701 2,578 1,306 1,164 525 457
Some College 2,730a 2,454 1,236b 1,007 438a 328
College Graduate 974 909 340 325 90 110
CURRENT EMPLOYMENT            
Full-Time 3,338 3,084 1,397a 1,193 551 455
Part-Time 2,016 1,913 909 869 288 298
Unemployed 1,085 983 581 486 260a 185
Other1 1,320 1,271 620 512 211 194
140320
Table 1.56B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 22.4b 20.8 10.1b 8.8 3.8a 3.3
GENDER            
Male 24.5 23.0 10.9 10.1 4.0 3.6
Female 20.4a 18.6 9.3b 7.5 3.6a 2.9
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 23.7b 21.7 10.9b 9.2 4.1a 3.4
White 26.5b 24.3 12.0b 10.2 4.4a 3.6
Black or African American 16.2 15.4 8.4 6.7 3.3 3.2
American Indian or Alaska Native 21.4 24.4 12.3 10.6 3.8 5.6
Native Hawaiian or Other Pacific Islander * 17.6 4.5 7.6 1.2 0.6
Asian 10.2 9.1 5.6 3.8 2.6 1.5
Two or More Races 34.2 27.1 12.6 12.5 4.4 3.7
Hispanic or Latino 17.6 17.6 7.2 7.3 2.8 2.6
EDUCATION            
< High School 25.4 23.5 11.7 10.1 4.9 4.2
High School Graduate 22.9 21.5 11.1a 9.7 4.5 3.8
Some College 22.1a 20.1 10.0b 8.3 3.5a 2.7
College Graduate 19.0 18.0 6.6 6.4 1.7 2.2
CURRENT EMPLOYMENT            
Full-Time 24.8a 22.8 10.4a 8.8 4.1 3.4
Part-Time 21.5 19.8 9.7 9.0 3.1 3.1
Unemployed 26.4 23.6 14.1a 11.7 6.3a 4.4
Other1 17.3 17.1 8.1 6.9 2.8 2.6
140320
Table 1.57A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 27,218 26,417 7,649 6,865 2,993 2,964
GENDER            
Male 15,553b 13,997 4,300a 3,501 1,711 1,578
Female 11,665 12,421 3,349 3,364 1,282 1,386
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 23,659 23,131 6,392 5,774 2,620 2,460
White 19,927 19,771 5,083 4,719 2,129 2,037
Black or African American 2,467 2,070 975a 626 364 327
American Indian or Alaska Native 192 154 72 57 42 3
Native Hawaiian or Other Pacific Islander * * 18 6 1 1
Asian 592 509 177 155 60 42
Two or More Races 365 503 67a 211 23 49
Hispanic or Latino 3,559 3,286 1,257 1,091 373 504
EDUCATION            
< High School 3,791b 2,860 1,404a 996 496 576
High School Graduate 7,785 7,249 2,163 2,030 895 907
Some College 8,212 8,170 2,383 2,038 810 883
College Graduate 7,429 8,138 1,699 1,801 791 598
CURRENT EMPLOYMENT            
Full-Time 16,690a 15,230 4,501a 3,677 1,734 1,424
Part-Time 3,143a 3,853 893 937 397 386
Unemployed 2,075a 1,529 667 591 333 311
Other1 5,310 5,806 1,589 1,659 530a 843
140320
Table 1.57B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 13.6 13.0 3.8 3.4 1.5 1.5
GENDER            
Male 16.2b 14.4 4.5b 3.6 1.8 1.6
Female 11.1 11.7 3.2 3.2 1.2 1.3
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 13.7 13.3 3.7 3.3 1.5 1.4
White 14.6 14.4 3.7 3.4 1.6 1.5
Black or African American 11.1 9.1 4.4a 2.7 1.6 1.4
American Indian or Alaska Native 18.7 15.2 7.0 5.6 4.0 0.3
Native Hawaiian or Other Pacific Islander * * 2.3 1.0 0.2 0.2
Asian 6.0 5.0 1.8 1.5 0.6 0.4
Two or More Races 13.7 17.9 2.5a 7.5 0.9 1.7
Hispanic or Latino 12.9 11.6 4.5 3.8 1.3 1.8
EDUCATION            
< High School 13.1a 10.8 4.9 3.7 1.7 2.2
High School Graduate 13.4 12.5 3.7 3.5 1.5 1.6
Some College 16.4 16.0 4.7 4.0 1.6 1.7
College Graduate 11.7 12.2 2.7 2.7 1.2 0.9
CURRENT EMPLOYMENT            
Full-Time 16.0b 14.4 4.3a 3.5 1.7 1.4
Part-Time 13.4a 16.0 3.8 3.9 1.7 1.6
Unemployed 21.9 20.0 7.0 7.7 3.5 4.1
Other1 8.4 8.9 2.5 2.5 0.8a 1.3
140320
Table 1.58A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Numbers in Thousands, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 34,977 33,668 11,157a 9,925 4,304 4,096
GENDER            
Male 19,797b 18,017 6,198b 5,259 2,396 2,209
Female 15,179 15,651 4,958 4,666 1,908 1,887
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 30,158 29,104 9,386a 8,307 3,734 3,401
White 25,100 24,514 7,428 6,716 2,989 2,748
Black or African American 3,263 2,840 1,387a 961 527 488
American Indian or Alaska Native 249 210 105 81 52 16
Native Hawaiian or Other Pacific Islander * * 27 21 4 2
Asian 774 679 277 226 107 70
Two or More Races 625 701 163a 303 57 76
Hispanic or Latino 4,818 4,564 1,771 1,618 570 695
EDUCATION            
< High School 5,145b 4,170 2,029a 1,561 755 814
High School Graduate 10,486 9,827 3,470 3,193 1,420 1,364
Some College 10,943 10,623 3,619a 3,045 1,248 1,210
College Graduate 8,403 9,047 2,040 2,126 881 708
CURRENT EMPLOYMENT            
Full-Time 20,027a 18,314 5,898b 4,870 2,285a 1,880
Part-Time 5,159 5,766 1,802 1,806 685 684
Unemployed 3,160b 2,511 1,248 1,078 593 495
Other1 6,630 7,077 2,209 2,172 741a 1,037
140320
Table 1.58B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Demographic Characteristics: Percentages, 2012 and 2013
Demographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 The Other Employment category includes students, persons keeping house or caring for children full time, retired or disabled persons, or other persons not in the labor force.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.9 14.2 4.7b 4.2 1.8 1.7
GENDER            
Male 17.5b 15.7 5.5b 4.6 2.1 1.9
Female 12.4 12.7 4.1 3.8 1.6 1.5
HISPANIC ORIGIN AND RACE            
Not Hispanic or Latino 15.1 14.4 4.7b 4.1 1.9 1.7
White 16.1 15.7 4.8a 4.3 1.9 1.8
Black or African American 12.0a 10.2 5.1b 3.5 1.9 1.8
American Indian or Alaska Native 19.2 16.9 8.1 6.5 4.0 1.3
Native Hawaiian or Other Pacific Islander * * 2.7 2.7 0.4 0.3
Asian 6.7 5.6 2.4 1.9 0.9 0.6
Two or More Races 18.3 19.8 4.8a 8.6 1.7 2.2
Hispanic or Latino 13.8 12.8 5.1 4.5 1.6 1.9
EDUCATION            
< High School 15.0a 13.0 5.9 4.9 2.2 2.5
High School Graduate 15.0 14.0 5.0 4.6 2.0 1.9
Some College 17.5 16.8 5.8a 4.8 2.0 1.9
College Graduate 12.3 12.6 3.0 3.0 1.3 1.0
CURRENT EMPLOYMENT            
Full-Time 17.0b 15.4 5.0b 4.1 1.9a 1.6
Part-Time 15.7 17.1 5.5 5.4 2.1 2.0
Unemployed 23.3 21.3 9.2 9.1 4.4 4.2
Other1 9.3 9.7 3.1 3.0 1.0a 1.4
140321
Table 1.59A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 124,808 127,458 41,479 41,591 23,863 24,573
GEOGRAPHIC DIVISION            
Northeast 23,047 22,722 7,808 7,461 4,527 4,362
New England 6,879 6,509 2,314 2,230 1,420 1,397
Middle Atlantic 16,168 16,212 5,494 5,232 3,107 2,965
Midwest 27,070 27,289 8,602 8,466 4,797 4,914
East North Central 19,440 19,168 6,401 6,141 3,665 3,629
West North Central 7,630 8,121 2,201 2,324 1,132 1,285
South 43,696 45,007 13,575 13,976 7,456 8,066
South Atlantic 24,180 25,276 7,266 8,100 4,217 4,584
East South Central 6,496 6,565 1,986 2,005 1,039 1,220
West South Central 13,020 13,167 4,323 3,871 2,200 2,261
West 30,995a 32,440 11,495 11,688 7,083 7,232
Mountain 9,619 10,042 3,284 3,493 1,894 2,124
Pacific 21,376 22,398 8,211 8,195 5,189 5,108
COUNTY TYPE            
Large Metro 67,668 69,365 23,815 22,999 13,724 13,565
Small Metro 38,944 39,350 12,388 13,018 7,250 7,694
250K - 1 Mil. Pop. 26,311 27,024 8,354 8,646 4,897 5,064
< 250K Pop. 12,634 12,326 4,035 4,372 2,353 2,630
Nonmetro 18,196 18,743 5,276 5,574 2,889 3,315
Urbanized 8,700 8,814 2,685 2,859 1,532 1,696
Less Urbanized 7,637 8,227 2,184 2,258 1,128 1,311
Completely Rural 1,860 1,702 407 457 229 308
140321
Table 1.59B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 48.0 48.6 16.0 15.9 9.2 9.4
GEOGRAPHIC DIVISION            
Northeast 48.9 47.9 16.6 15.7 9.6 9.2
New England 55.4 52.1 18.6 17.9 11.4 11.2
Middle Atlantic 46.5 46.4 15.8 15.0 8.9 8.5
Midwest 48.4 48.5 15.4 15.1 8.6 8.7
East North Central 50.1 49.2 16.5 15.8 9.4 9.3
West North Central 44.6 47.1 12.9 13.5 6.6 7.5
South 45.3 46.2 14.1 14.3 7.7 8.3
South Atlantic 47.5 49.1 14.3 15.7 8.3 8.9
East South Central 42.2 42.4 12.9 12.9 6.7 7.9
West South Central 43.2 43.1 14.4a 12.7 7.3 7.4
West 51.2 52.9 19.0 19.1 11.7 11.8
Mountain 52.2 53.7 17.8 18.7 10.3 11.4
Pacific 50.7 52.6 19.5 19.2 12.3 12.0
COUNTY TYPE            
Large Metro 48.6 49.2 17.1 16.3 9.9 9.6
Small Metro 49.6 49.9 15.8 16.5 9.2 9.8
250K - 1 Mil. Pop. 49.7 50.6 15.8 16.2 9.3 9.5
< 250K Pop. 49.3 48.3 15.8 17.1 9.2 10.3
Nonmetro 43.1 44.2 12.5 13.1 6.8 7.8
Urbanized 47.1 46.4 14.5 15.0 8.3 8.9
Less Urbanized 40.2 43.3 11.5 11.9 5.9 6.9
Completely Rural 39.0 38.1 8.5 10.2 4.8 6.9
140321
Table 1.60A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 6,044 5,794 4,468 4,287 2,377a 2,197
GEOGRAPHIC DIVISION            
Northeast 979 946 743 758 398 391
New England 273 253 224 204 128 113
Middle Atlantic 706 693 518 554 270 278
Midwest 1,285a 1,171 951 879 512a 445
East North Central 924 848 682 649 366 324
West North Central 361 322 269 231 145 121
South 2,258 2,163 1,655 1,517 849a 739
South Atlantic 1,182 1,170 870 830 462 393
East South Central 330 308 226 230 104 111
West South Central 746 686 559a 457 283 236
West 1,523 1,514 1,120 1,132 617 622
Mountain 494 508 364 375 218 217
Pacific 1,029 1,006 756 757 399 405
COUNTY TYPE            
Large Metro 3,312 3,136 2,480 2,371 1,295 1,223
Small Metro 1,815 1,785 1,330 1,319 716 665
250K - 1 Mil. Pop. 1,234 1,210 922 896 514 454
< 250K Pop. 581 575 408 423 202 211
Nonmetro 917 872 658 597 365 309
Urbanized 446 374 315 271 169 142
Less Urbanized 379 423 269 275 149 141
Completely Rural 92 75 74 51 48 26
140321
Table 1.60B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 24.2 23.3 17.9 17.2 9.5a 8.8
GEOGRAPHIC DIVISION            
Northeast 23.1 22.6 17.5 18.1 9.4 9.3
New England 24.8 23.2 20.3 18.7 11.6 10.4
Middle Atlantic 22.5 22.4 16.5 17.9 8.6 9.0
Midwest 23.7a 21.7 17.6 16.3 9.4 8.2
East North Central 24.4 22.6 18.0 17.3 9.7 8.6
West North Central 22.0 19.7 16.5 14.1 8.9 7.3
South 24.3 23.1 17.8 16.2 9.1a 7.9
South Atlantic 25.5 25.1 18.7 17.8 10.0 8.4
East South Central 22.3 20.9 15.3 15.6 7.1 7.5
West South Central 23.4 21.3 17.5a 14.2 8.9 7.3
West 25.5 25.4 18.7 19.0 10.3 10.5
Mountain 26.6 27.1 19.6 20.0 11.8 11.6
Pacific 25.0 24.7 18.4 18.6 9.7 9.9
COUNTY TYPE            
Large Metro 24.4 23.1 18.2 17.5 9.5 9.0
Small Metro 24.5 24.0 17.9 17.7 9.7 8.9
250K - 1 Mil. Pop. 24.1 23.6 18.0 17.5 10.1 8.9
< 250K Pop. 25.3 24.7 17.8 18.2 8.8 9.1
Nonmetro 23.4 22.4 16.8 15.4 9.3 8.0
Urbanized 24.6 22.5 17.4 16.3 9.3 8.5
Less Urbanized 22.4 23.7 15.9 15.4 8.8 7.9
Completely Rural 22.1 16.9 17.9a 11.5 11.5a 6.0
140321
Table 1.61A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 19,977 19,826 12,551 12,448 7,381 7,490
GEOGRAPHIC DIVISION            
Northeast 3,692 3,587 2,535 2,361 1,528 1,425
New England 1,048 1,083 739 790 460 491
Middle Atlantic 2,643 2,504 1,796b 1,571 1,068 935
Midwest 4,255 4,311 2,587 2,648 1,478 1,602
East North Central 2,984 2,954 1,814 1,872 1,121 1,114
West North Central 1,271 1,357 773 776 357b 488
South 7,040 6,955 4,228 4,160 2,385 2,412
South Atlantic 3,666 3,669 2,288 2,277 1,350 1,323
East South Central 1,087 1,059 623 614 351 365
West South Central 2,288 2,227 1,317 1,269 684 724
West 4,989 4,973 3,201 3,280 1,991 2,051
Mountain 1,512 1,496 922 918 556 582
Pacific 3,477 3,476 2,280 2,362 1,435 1,470
COUNTY TYPE            
Large Metro 11,244 10,832 7,295 7,071 4,420 4,344
Small Metro 6,181 6,235 3,836 3,778 2,177 2,200
250K - 1 Mil. Pop. 3,936 4,031 2,431 2,441 1,358 1,399
< 250K Pop. 2,245 2,203 1,405 1,337 819 800
Nonmetro 2,551 2,760 1,420 1,599 784a 947
Urbanized 1,234 1,341 731 807 397 499
Less Urbanized 1,125 1,207 587 680 335 392
Completely Rural 192 211 102 112 52 56
140321
Table 1.61B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 57.8 57.0 36.3 35.8 21.3 21.5
GEOGRAPHIC DIVISION            
Northeast 60.0 58.3 41.2 38.4 24.8 23.2
New England 64.7 66.5 45.6 48.5 28.4 30.1
Middle Atlantic 58.3 55.4 39.6b 34.8 23.5 20.7
Midwest 57.8 58.2 35.1 35.7 20.1 21.6
East North Central 58.8 57.9 35.7 36.7 22.1 21.8
West North Central 55.6 58.9 33.8 33.7 15.6b 21.2
South 55.2 54.1 33.1 32.4 18.7 18.8
South Atlantic 56.2 55.9 35.1 34.7 20.7 20.2
East South Central 53.7 51.9 30.8 30.1 17.3 17.9
West South Central 54.3 52.3 31.3 29.8 16.2 17.0
West 60.0 59.4 38.5 39.2 23.9 24.5
Mountain 60.6 59.1 37.0 36.3 22.3 23.0
Pacific 59.7 59.5 39.2 40.4 24.6 25.2
COUNTY TYPE            
Large Metro 59.4 57.8 38.5 37.7 23.4 23.2
Small Metro 57.2 57.3 35.5 34.8 20.1 20.2
250K - 1 Mil. Pop. 57.1 57.7 35.3 34.9 19.7 20.0
< 250K Pop. 57.2 56.8 35.8 34.5 20.9 20.6
Nonmetro 52.6 53.4 29.3 30.9 16.2 18.3
Urbanized 55.5 54.2 32.9 32.6 17.9 20.2
Less Urbanized 51.5 54.3 26.9 30.6 15.4 17.6
Completely Rural 42.9 44.6 22.8 23.7 11.6 11.8
140321
Table 1.62A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 98,787a 101,838 24,460 24,856 14,105 14,886
GEOGRAPHIC DIVISION            
Northeast 18,376 18,188 4,531 4,342 2,601 2,546
New England 5,557 5,172 1,351 1,236 832 793
Middle Atlantic 12,818 13,016 3,180 3,107 1,769 1,753
Midwest 21,530 21,807 5,063 4,939 2,808 2,867
East North Central 15,531 15,365 3,905 3,621 2,178 2,190
West North Central 5,999 6,442 1,158 1,318 630 677
South 34,398 35,889 7,692 8,299 4,222 4,915
South Atlantic 19,332 20,437 4,108a 4,993 2,405 2,869
East South Central 5,080 5,198 1,137 1,160 584 745
West South Central 9,986 10,254 2,447 2,146 1,233 1,302
West 24,483a 25,953 7,174 7,276 4,474 4,558
Mountain 7,614 8,038 1,999 2,200 1,119 1,325
Pacific 16,870 17,916 5,175 5,076 3,355 3,233
COUNTY TYPE            
Large Metro 53,111 55,396 14,041 13,557 8,009 7,998
Small Metro 30,948 31,330 7,222 7,921 4,357 4,829
250K - 1 Mil. Pop. 21,141 21,783 5,001 5,309 3,025 3,210
< 250K Pop. 9,807 9,548 2,221 2,611 1,332 1,619
Nonmetro 14,729 15,111 3,197 3,378 1,739 2,059
Urbanized 7,019 7,099 1,640 1,781 966 1,056
Less Urbanized 6,133 6,597 1,327 1,303 644 778
Completely Rural 1,576 1,416 231 294 129 225
140321
Table 1.62B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 49.3 50.2 12.2 12.3 7.0 7.3
GEOGRAPHIC DIVISION            
Northeast 50.0 49.1 12.3 11.7 7.1 6.9
New England 57.4 53.0 13.9 12.7 8.6 8.1
Middle Atlantic 47.3 47.7 11.7 11.4 6.5 6.4
Midwest 49.9 50.2 11.7 11.4 6.5 6.6
East North Central 51.8 51.0 13.0 12.0 7.3 7.3
West North Central 45.5 48.5 8.8 9.9 4.8 5.1
South 46.3 47.7 10.4 11.0 5.7 6.5
South Atlantic 48.7 50.8 10.4 12.4 6.1 7.1
East South Central 42.7 43.4 9.6 9.7 4.9 6.2
West South Central 43.9 44.4 10.8 9.3 5.4 5.6
West 52.9 55.3 15.5 15.5 9.7 9.7
Mountain 54.1 56.2 14.2 15.4 8.0 9.3
Pacific 52.4 54.9 16.1 15.5 10.4 9.9
COUNTY TYPE            
Large Metro 49.7 50.9 13.1 12.5 7.5 7.4
Small Metro 51.3 51.7 12.0 13.1 7.2 8.0
250K - 1 Mil. Pop. 51.7 52.8 12.2 12.9 7.4 7.8
< 250K Pop. 50.6 49.5 11.5 13.5 6.9 8.4
Nonmetro 44.0 45.2 9.6 10.1 5.2 6.2
Urbanized 48.6 47.8 11.3 12.0 6.7 7.1
Less Urbanized 40.6 44.0 8.8 8.7 4.3 5.2
Completely Rural 40.4 39.9 5.9 8.3 3.3 6.4
140321
Table 1.63A – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 118,764a 121,664 37,011 37,304 21,486 22,376
GEOGRAPHIC DIVISION            
Northeast 22,068 21,775 7,065 6,703 4,129 3,971
New England 6,606 6,256 2,090 2,026 1,292 1,283
Middle Atlantic 15,462 15,519 4,976 4,677 2,837 2,688
Midwest 25,785 26,118 7,651 7,586 4,285 4,469
East North Central 18,516 18,320 5,719 5,493 3,299 3,304
West North Central 7,269 7,798 1,931 2,094 987 1,164
South 41,438 42,844 11,920 12,459 6,607 7,327
South Atlantic 22,998 24,106 6,397 7,269 3,755 4,191
East South Central 6,166 6,257 1,760 1,775 935 1,110
West South Central 12,274 12,481 3,764 3,414 1,917 2,026
West 29,473a 30,926 10,375 10,556 6,466 6,610
Mountain 9,126 9,534 2,920 3,118 1,676 1,907
Pacific 20,347 21,392 7,455 7,438 4,790 4,703
COUNTY TYPE            
Large Metro 64,355 66,228 21,335 20,627 12,429 12,342
Small Metro 37,129 37,565 11,058 11,699 6,534 7,028
250K - 1 Mil. Pop. 25,077 25,814 7,432 7,751 4,383 4,609
< 250K Pop. 12,052 11,751 3,626 3,949 2,150 2,419
Nonmetro 17,280 17,871 4,617 4,977 2,524a 3,006
Urbanized 8,253 8,441 2,370 2,588 1,364 1,554
Less Urbanized 7,258 7,804 1,915 1,983 979 1,170
Completely Rural 1,768 1,627 333 406 181 281
140321
Table 1.63B – Illicit Drug Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Illicit Drugs include marijuana/hashish, cocaine (including crack), heroin, hallucinogens, inhalants, or prescription-type psychotherapeutics used nonmedically, including data from original methamphetamine questions but not including new methamphetamine items added in 2005 and 2006.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 50.5 51.2 15.7 15.7 9.1 9.4
GEOGRAPHIC DIVISION            
Northeast 51.4 50.4 16.5 15.5 9.6 9.2
New England 58.4 54.9 18.5 17.8 11.4 11.3
Middle Atlantic 48.9 48.8 15.7 14.7 9.0 8.4
Midwest 51.1 51.4 15.1 14.9 8.5 8.8
East North Central 52.8 52.0 16.3 15.6 9.4 9.4
West North Central 47.0 50.0 12.5 13.4 6.4 7.5
South 47.6 48.6 13.7 14.1 7.6 8.3
South Atlantic 49.8 51.5 13.8 15.5 8.1 9.0
East South Central 44.3 44.6 12.6 12.7 6.7 7.9
West South Central 45.6 45.7 14.0 12.5 7.1 7.4
West 54.0 55.9 19.0 19.1 11.8 11.9
Mountain 55.1 56.7 17.6 18.5 10.1 11.3
Pacific 53.5 55.6 19.6 19.3 12.6 12.2
COUNTY TYPE            
Large Metro 51.2 52.0 17.0 16.2 9.9 9.7
Small Metro 52.2 52.6 15.6 16.4 9.2 9.8
250K - 1 Mil. Pop. 52.5 53.5 15.6 16.1 9.2 9.5
< 250K Pop. 51.7 50.7 15.6 17.0 9.2 10.4
Nonmetro 45.1 46.3 12.0 12.9 6.6a 7.8
Urbanized 49.5 48.7 14.2 14.9 8.2 9.0
Less Urbanized 42.0 45.4 11.1 11.5 5.7 6.8
Completely Rural 40.6 40.4 7.6 10.1 4.2 7.0
140321
Table 1.64A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 111,239a 114,712 31,513 32,952 18,855 19,810
GEOGRAPHIC DIVISION            
Northeast 20,986 21,007 6,366 6,156 3,718 3,598
New England 6,448 6,081 1,974 1,944 1,235 1,263
Middle Atlantic 14,538 14,927 4,392 4,212 2,483 2,336
Midwest 24,550 24,956 6,512 6,772 3,787 4,007
East North Central 17,642 17,537 4,810 4,932 2,869 2,969
West North Central 6,908 7,419 1,702 1,840 917 1,038
South 38,384 39,685 9,878 10,602 5,626 6,274
South Atlantic 21,431 22,283 5,547 6,244 3,380 3,748
East South Central 5,737 6,013 1,364 1,531 720 870
West South Central 11,216 11,389 2,967 2,828 1,527 1,656
West 27,319a 29,064 8,757 9,421 5,725 5,932
Mountain 8,370 9,034 2,447 2,742 1,493 1,764
Pacific 18,949 20,030 6,311 6,679 4,232 4,168
COUNTY TYPE            
Large Metro 60,058 62,270 17,850 18,403 10,625 10,941
Small Metro 34,992 35,494 9,755 10,386 5,870 6,200
250K - 1 Mil. Pop. 23,662 24,559 6,493 6,869 3,905 4,068
< 250K Pop. 11,330 10,935 3,263 3,517 1,965 2,132
Nonmetro 16,189 16,948 3,908 4,163 2,360 2,669
Urbanized 7,738 8,037 2,000 2,164 1,289 1,423
Less Urbanized 6,777 7,369 1,592 1,657 887 1,014
Completely Rural 1,674 1,542 316 342 184 232
140321
Table 1.64B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 42.8 43.7 12.1 12.6 7.3 7.5
GEOGRAPHIC DIVISION            
Northeast 44.5 44.3 13.5 13.0 7.9 7.6
New England 51.9 48.7 15.9 15.6 9.9 10.1
Middle Atlantic 41.8 42.8 12.6 12.1 7.1 6.7
Midwest 43.9 44.4 11.6 12.0 6.8 7.1
East North Central 45.4 45.0 12.4 12.7 7.4 7.6
West North Central 40.4 43.0 10.0 10.7 5.4 6.0
South 39.8 40.7 10.2 10.9 5.8 6.4
South Atlantic 42.1 43.3 10.9 12.1 6.6 7.3
East South Central 37.3 38.8 8.9 9.9 4.7 5.6
West South Central 37.2 37.3 9.8 9.3 5.1 5.4
West 45.1 47.4 14.5 15.4 9.4 9.7
Mountain 45.4 48.3 13.3 14.7 8.1 9.4
Pacific 44.9 47.0 15.0 15.7 10.0 9.8
COUNTY TYPE            
Large Metro 43.1 44.1 12.8 13.0 7.6 7.8
Small Metro 44.6 45.0 12.4 13.2 7.5 7.9
250K - 1 Mil. Pop. 44.7 46.0 12.3 12.9 7.4 7.6
< 250K Pop. 44.2 42.9 12.7 13.8 7.7 8.4
Nonmetro 38.3 39.9 9.3 9.8 5.6 6.3
Urbanized 41.9 42.3 10.8 11.4 7.0 7.5
Less Urbanized 35.7 38.8 8.4 8.7 4.7 5.3
Completely Rural 35.1 34.5 6.6 7.7 3.9 5.2
140321
Table 1.65A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 4,232 4,093 3,363 3,346 1,800 1,762
GEOGRAPHIC DIVISION            
Northeast 716 740 601 624 333 337
New England 217 203 189 176 111 102
Middle Atlantic 499 537 413 448 222 235
Midwest 893 842 727 700 401 367
East North Central 635 619 517 514 285 268
West North Central 259 223 210 187 116 98
South 1,504 1,404 1,202 1,120 617 540
South Atlantic 826 769 668 619 358a 290
East South Central 197 197 145 165 64 80
West South Central 481 438 389 336 194 170
West 1,118 1,107 832 902 449 519
Mountain 356 387 259 316 150 186
Pacific 762 720 573 586 299 333
COUNTY TYPE            
Large Metro 2,385 2,228 1,897 1,846 982 997
Small Metro 1,241 1,270 988 1,049 540 533
250K - 1 Mil. Pop. 863 869 684 711 386 378
< 250K Pop. 378 401 304 338 154 155
Nonmetro 606 595 478 451 278 232
Urbanized 288 265 226 206 129 112
Less Urbanized 256 281 200 207 116 99
Completely Rural 62 49 52 38 33 21
140321
Table 1.65B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 17.0 16.4 13.5 13.4 7.2 7.1
GEOGRAPHIC DIVISION            
Northeast 16.9 17.7 14.2 14.9 7.9 8.0
New England 19.7 18.6 17.1 16.1 10.0 9.3
Middle Atlantic 15.9 17.4 13.2 14.5 7.1 7.6
Midwest 16.5 15.6 13.4 13.0 7.4 6.8
East North Central 16.8 16.5 13.7 13.7 7.6 7.1
West North Central 15.8 13.6 12.8 11.4 7.1 6.0
South 16.2 15.0 12.9 12.0 6.6 5.8
South Atlantic 17.8 16.5 14.4 13.3 7.7a 6.2
East South Central 13.3 13.3 9.8 11.2 4.3 5.4
West South Central 15.1 13.6 12.2 10.4 6.1 5.3
West 18.7 18.6 13.9 15.2 7.5 8.7
Mountain 19.2 20.6 13.9 16.9 8.1 9.9
Pacific 18.5 17.7 13.9 14.4 7.3 8.2
COUNTY TYPE            
Large Metro 17.5 16.4 13.9 13.6 7.2 7.4
Small Metro 16.7 17.0 13.3 14.1 7.3 7.2
250K - 1 Mil. Pop. 16.9 17.0 13.4 13.9 7.5 7.4
< 250K Pop. 16.4 17.2 13.2 14.6 6.7 6.7
Nonmetro 15.4 15.3 12.2 11.6 7.1 6.0
Urbanized 15.9 16.0 12.5 12.4 7.1 6.7
Less Urbanized 15.1 15.8 11.8 11.6 6.8 5.6
Completely Rural 14.9 11.1 12.5 8.7 8.0 4.7
140321
Table 1.66A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 18,052 18,051 10,887 11,000 6,485 6,636
GEOGRAPHIC DIVISION            
Northeast 3,447 3,312 2,300a 2,082 1,355 1,255
New England 984 1,022 680 727 424 462
Middle Atlantic 2,462a 2,290 1,619b 1,355 931a 793
Midwest 3,833 3,956 2,214 2,349 1,311 1,434
East North Central 2,707 2,709 1,561 1,661 994 998
West North Central 1,125a 1,247 652 688 317b 436
South 6,321 6,210 3,603 3,650 2,033 2,093
South Atlantic 3,324 3,331 1,994 2,023 1,178 1,162
East South Central 971 932 510 541 285 308
West South Central 2,027 1,947 1,099 1,086 570 623
West 4,451 4,573 2,771 2,920 1,786 1,854
Mountain 1,346 1,385 773 825 478 514
Pacific 3,106 3,187 1,999 2,094 1,308 1,340
COUNTY TYPE            
Large Metro 10,139 9,893 6,347 6,298 3,898 3,856
Small Metro 5,621 5,676 3,336 3,315 1,930 1,927
250K - 1 Mil. Pop. 3,552 3,707 2,082 2,135 1,191 1,229
< 250K Pop. 2,068 1,968 1,254 1,180 739 699
Nonmetro 2,293 2,482 1,204a 1,387 657b 853
Urbanized 1,113 1,189 623 709 344a 456
Less Urbanized 1,005 1,109 496 582 263 344
Completely Rural 174 184 86 95 50 52
140321
Table 1.66B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 52.2 51.9 31.5 31.6 18.7 19.1
GEOGRAPHIC DIVISION            
Northeast 56.0 53.9 37.4a 33.9 22.0 20.4
New England 60.8 62.7 42.0 44.6 26.2 28.3
Middle Atlantic 54.3a 50.7 35.7b 30.0 20.5a 17.6
Midwest 52.1 53.4 30.1 31.7 17.8 19.4
East North Central 53.3 53.1 30.8 32.5 19.6 19.6
West North Central 49.2a 54.2 28.5 29.9 13.9b 18.9
South 49.5 48.3 28.2 28.4 15.9 16.3
South Atlantic 50.9 50.8 30.5 30.8 18.0 17.7
East South Central 48.0 45.7 25.2 26.5 14.1 15.1
West South Central 48.2 45.8 26.1 25.5 13.5 14.6
West 53.5 54.6 33.3 34.9 21.5 22.1
Mountain 54.0 54.7 31.0 32.6 19.2 20.3
Pacific 53.3 54.6 34.3 35.9 22.5 22.9
COUNTY TYPE            
Large Metro 53.6 52.8 33.5 33.6 20.6 20.6
Small Metro 52.0 52.2 30.9 30.5 17.8 17.7
250K - 1 Mil. Pop. 51.6 53.0 30.2 30.5 17.3 17.6
< 250K Pop. 52.7 50.7 32.0 30.4 18.8 18.0
Nonmetro 47.3 48.0 24.8 26.8 13.5b 16.5
Urbanized 50.1 48.1 28.0 28.7 15.5 18.5
Less Urbanized 46.1 49.9 22.7 26.2 12.1a 15.5
Completely Rural 39.0 38.8 19.2 20.1 11.2 11.1
140321
Table 1.67A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 88,955b 92,568 17,263 18,606 10,571 11,412
GEOGRAPHIC DIVISION            
Northeast 16,823 16,956 3,465 3,450 2,030 2,006
New England 5,246 4,856 1,105 1,041 700 699
Middle Atlantic 11,577 12,099 2,360 2,409 1,330 1,308
Midwest 19,824 20,157 3,571 3,723 2,074 2,206
East North Central 14,300 14,208 2,731 2,758 1,590 1,702
West North Central 5,524 5,949 840 966 484 503
South 30,559 32,071 5,073 5,833 2,977a 3,641
South Atlantic 17,281 18,183 2,886a 3,601 1,843 2,296
East South Central 4,570 4,884 709 825 371 481
West South Central 8,708 9,004 1,479 1,406 763 864
West 21,750a 23,384 5,154 5,599 3,490 3,560
Mountain 6,668 7,262 1,415 1,601 864 1,065
Pacific 15,082 16,123 3,739 3,998 2,626 2,495
COUNTY TYPE            
Large Metro 47,534 50,148 9,606 10,259 5,746 6,088
Small Metro 28,131 28,549 5,431 6,022 3,400 3,739
250K - 1 Mil. Pop. 19,247 19,983 3,727 4,024 2,328 2,461
< 250K Pop. 8,884 8,566 1,705 1,998 1,072 1,278
Nonmetro 13,290 13,871 2,225 2,325 1,424 1,585
Urbanized 6,336 6,583 1,151 1,250 816 854
Less Urbanized 5,516 5,979 896 868 508 571
Completely Rural 1,438 1,309 178 208 101 159
140321
Table 1.67B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 44.4 45.7 8.6 9.2 5.3 5.6
GEOGRAPHIC DIVISION            
Northeast 45.7 45.8 9.4 9.3 5.5 5.4
New England 54.2 49.8 11.4 10.7 7.2 7.2
Middle Atlantic 42.7 44.3 8.7 8.8 4.9 4.8
Midwest 45.9 46.4 8.3 8.6 4.8 5.1
East North Central 47.7 47.2 9.1 9.2 5.3 5.7
West North Central 41.9 44.8 6.4 7.3 3.7 3.8
South 41.1 42.6 6.8 7.7 4.0 4.8
South Atlantic 43.5 45.2 7.3 9.0 4.6 5.7
East South Central 38.4 40.8 6.0 6.9 3.1 4.0
West South Central 38.3 39.0 6.5 6.1 3.4 3.7
West 47.0 49.8 11.1 11.9 7.5 7.6
Mountain 47.4 50.8 10.1 11.2 6.1 7.4
Pacific 46.8 49.4 11.6 12.2 8.1 7.6
COUNTY TYPE            
Large Metro 44.5 46.1 9.0 9.4 5.4 5.6
Small Metro 46.7 47.1 9.0 9.9 5.6 6.2
250K - 1 Mil. Pop. 47.1 48.4 9.1 9.7 5.7 6.0
< 250K Pop. 45.8 44.4 8.8 10.4 5.5 6.6
Nonmetro 39.7 41.5 6.6 7.0 4.3 4.7
Urbanized 43.9 44.3 8.0 8.4 5.6 5.7
Less Urbanized 36.5 39.9 5.9 5.8 3.4 3.8
Completely Rural 36.8 36.9 4.6 5.9 2.6 4.5
140321
Table 1.68A – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 107,007b 110,619 28,150 29,606 17,055 18,048
GEOGRAPHIC DIVISION            
Northeast 20,270 20,267 5,764 5,532 3,385 3,262
New England 6,231 5,878 1,785 1,768 1,124 1,161
Middle Atlantic 14,039 14,389 3,979 3,764 2,261 2,101
Midwest 23,656 24,114 5,785 6,072 3,385 3,640
East North Central 17,007 16,917 4,292 4,418 2,584 2,701
West North Central 6,649 7,197 1,493 1,654 801 939
South 36,880 38,281 8,676 9,483 5,009a 5,734
South Atlantic 20,604 21,514 4,880 5,624 3,021 3,458
East South Central 5,541 5,816 1,219 1,366 656 789
West South Central 10,735 10,951 2,577 2,492 1,332 1,486
West 26,201a 27,957 7,925 8,519 5,276 5,413
Mountain 8,013 8,647 2,188 2,426 1,342 1,579
Pacific 18,188 19,310 5,737 6,093 3,933 3,835
COUNTY TYPE            
Large Metro 57,673 60,041 15,953 16,557 9,644 9,944
Small Metro 33,751 34,225 8,767 9,337 5,330 5,667
250K - 1 Mil. Pop. 22,799 23,691 5,809 6,158 3,519 3,690
< 250K Pop. 10,952 10,534 2,959 3,178 1,811 1,977
Nonmetro 15,583 16,353 3,430 3,712 2,082 2,437
Urbanized 7,450 7,772 1,774 1,959 1,160 1,311
Less Urbanized 6,521 7,088 1,392 1,450 771 915
Completely Rural 1,612 1,493 264 303 151 211
140321
Table 1.68B – Marijuana Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 45.5 46.6 12.0 12.5 7.3 7.6
GEOGRAPHIC DIVISION            
Northeast 47.2 46.9 13.4 12.8 7.9 7.5
New England 55.1 51.6 15.8 15.5 9.9 10.2
Middle Atlantic 44.4 45.2 12.6 11.8 7.1 6.6
Midwest 46.8 47.5 11.5 11.9 6.7 7.2
East North Central 48.5 48.0 12.3 12.5 7.4 7.7
West North Central 43.0 46.2 9.6 10.6 5.2 6.0
South 42.4 43.4 10.0 10.8 5.8 6.5
South Atlantic 44.6 46.0 10.6 12.0 6.5 7.4
East South Central 39.8 41.5 8.8 9.7 4.7 5.6
West South Central 39.9 40.1 9.6 9.1 4.9 5.4
West 48.0 50.5 14.5 15.4 9.7 9.8
Mountain 48.4 51.4 13.2 14.4 8.1 9.4
Pacific 47.8 50.2 15.1 15.8 10.3 10.0
COUNTY TYPE            
Large Metro 45.9 47.1 12.7 13.0 7.7 7.8
Small Metro 47.5 47.9 12.3 13.1 7.5 7.9
250K - 1 Mil. Pop. 47.7 49.1 12.2 12.8 7.4 7.6
< 250K Pop. 47.0 45.4 12.7 13.7 7.8 8.5
Nonmetro 40.7 42.4 9.0 9.6 5.4 6.3
Urbanized 44.7 44.8 10.6 11.3 7.0 7.6
Less Urbanized 37.7 41.2 8.0 8.4 4.5 5.3
Completely Rural 37.0 37.1 6.1 7.5 3.5 5.2
140321
Table 1.69A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 37,688 37,634 4,671 4,182 1,650 1,549
GEOGRAPHIC DIVISION            
Northeast 7,025 7,016 1,042 873 387 261
New England 2,240 2,081 239 306 114 77
Middle Atlantic 4,785 4,935 803a 566 273 184
Midwest 7,319 6,897 720 738 287 250
East North Central 5,377 4,852 560 591 224 195
West North Central 1,942 2,045 160 147 62 55
South 12,161 12,806 1,612 1,355 576 590
South Atlantic 6,757 7,122 970 841 356 410
East South Central 1,617 1,808 200 141 90 58
West South Central 3,786 3,876 443 373 131 122
West 11,183 10,915 1,297 1,216 400 448
Mountain 3,426 3,220 419 360 131 137
Pacific 7,757 7,695 878 856 269 311
COUNTY TYPE            
Large Metro 21,028 20,349 2,918 2,529 1,098 961
Small Metro 11,904 11,711 1,381 1,246 431 412
250K - 1 Mil. Pop. 8,116 8,113 989 893 292 312
< 250K Pop. 3,789 3,598 392 353 139 101
Nonmetro 4,756a 5,574 371 407 121 175
Urbanized 2,397 2,742 154 198 59 49
Less Urbanized 1,992 2,289 167 150 34 77
Completely Rural 367 543 51 59 28 49
140321
Table 1.69B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.5 14.3 1.8 1.6 0.6 0.6
GEOGRAPHIC DIVISION            
Northeast 14.9 14.8 2.2 1.8 0.8 0.6
New England 18.0 16.7 1.9 2.5 0.9 0.6
Middle Atlantic 13.8 14.1 2.3a 1.6 0.8 0.5
Midwest 13.1 12.3 1.3 1.3 0.5 0.4
East North Central 13.9 12.4 1.4 1.5 0.6 0.5
West North Central 11.4 11.9 0.9 0.9 0.4 0.3
South 12.6 13.1 1.7 1.4 0.6 0.6
South Atlantic 13.3 13.8 1.9 1.6 0.7 0.8
East South Central 10.5 11.7 1.3 0.9 0.6 0.4
West South Central 12.6 12.7 1.5 1.2 0.4 0.4
West 18.5 17.8 2.1 2.0 0.7 0.7
Mountain 18.6 17.2 2.3 1.9 0.7 0.7
Pacific 18.4 18.1 2.1 2.0 0.6 0.7
COUNTY TYPE            
Large Metro 15.1 14.4 2.1 1.8 0.8 0.7
Small Metro 15.2 14.8 1.8 1.6 0.5 0.5
250K - 1 Mil. Pop. 15.3 15.2 1.9 1.7 0.6 0.6
< 250K Pop. 14.8 14.1 1.5 1.4 0.5 0.4
Nonmetro 11.3a 13.1 0.9 1.0 0.3 0.4
Urbanized 13.0 14.4 0.8 1.0 0.3 0.3
Less Urbanized 10.5 12.1 0.9 0.8 0.2 0.4
Completely Rural 7.7a 12.2 1.1 1.3 0.6 1.1
140321
Table 1.70A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 265 215 180a 131 30 43
GEOGRAPHIC DIVISION            
Northeast 35 25 24 15 6 6
New England 9 5 6 3 1 0
Middle Atlantic 26 20 17 12 5 5
Midwest 40 31 20 16 5 4
East North Central 34 20 14 9 4 2
West North Central 6 11 6 8 1 2
South 104 85 79 48 14 15
South Atlantic 27a 53 23 30 2 10
East South Central 16 9 13 6 4 3
West South Central 61b 24 43b 12 8 2
West 86 75 57 52 5a 19
Mountain 34 38 21 23 0 6
Pacific 52 37 36 29 5 14
COUNTY TYPE            
Large Metro 146 103 102a 62 15 20
Small Metro 81 84 58 57 10 19
250K - 1 Mil. Pop. 60 48 43 36 7 10
< 250K Pop. 21 36 15 22 3 9
Nonmetro 39 29 20 12 5 4
Urbanized 16 16 7 6 3 *
Less Urbanized 20 11 11 6 2 4
Completely Rural * 1 * * * *
140321
Table 1.70B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 1.1 0.9 0.7a 0.5 0.1 0.2
GEOGRAPHIC DIVISION            
Northeast 0.8 0.6 0.6 0.4 0.1 0.1
New England 0.8 0.4 0.6 0.3 0.1 0.0
Middle Atlantic 0.8 0.7 0.6 0.4 0.2 0.2
Midwest 0.7 0.6 0.4 0.3 0.1 0.1
East North Central 0.9 0.5 0.4 0.2 0.1 0.0
West North Central 0.4 0.7 0.3 0.5 0.1 0.1
South 1.1 0.9 0.9 0.5 0.2 0.2
South Atlantic 0.6a 1.1 0.5 0.7 0.0 0.2
East South Central 1.1 0.6 0.9 0.4 0.3 0.2
West South Central 1.9b 0.7 1.4b 0.4 0.2 0.1
West 1.4 1.3 1.0 0.9 0.1a 0.3
Mountain 1.8 2.0 1.1 1.2 0.0 0.3
Pacific 1.3 0.9 0.9 0.7 0.1 0.3
COUNTY TYPE            
Large Metro 1.1 0.8 0.7a 0.5 0.1 0.1
Small Metro 1.1 1.1 0.8 0.8 0.1 0.3
250K - 1 Mil. Pop. 1.2 0.9 0.8 0.7 0.1 0.2
< 250K Pop. 0.9 1.5 0.6 0.9 0.1 0.4
Nonmetro 1.0 0.7 0.5 0.3 0.1 0.1
Urbanized 0.9 1.0 0.4 0.4 0.2 *
Less Urbanized 1.2 0.6 0.6 0.3 0.1 0.2
Completely Rural * 0.3 * * * *
140321
Table 1.71A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 4,267 4,041 1,600 1,543 398 398
GEOGRAPHIC DIVISION            
Northeast 761 759 339 332 85 77
New England 217 220 92 113 30 20
Middle Atlantic 544 539 246 218 55 57
Midwest 786 766 217 270 56 67
East North Central 543 504 157 206 45 50
West North Central 242 262 60 64 10 17
South 1,495 1,340 526 440 143 113
South Atlantic 765 675 310 235 89 63
East South Central 195 187 59 56 21 13
West South Central 535 478 158 149 34 37
West 1,226 1,175 518 502 114 140
Mountain 433 386 155 122 39 39
Pacific 793 789 363 380 74 101
COUNTY TYPE            
Large Metro 2,429 2,204 1,007 887 254 234
Small Metro 1,298 1,219 452 485 111 130
250K - 1 Mil. Pop. 814 832 291 320 75 90
< 250K Pop. 484a 387 162 165 36 39
Nonmetro 541 618 141 171 32 34
Urbanized 273 328 72 108 17 18
Less Urbanized 231 249 59 54 10 14
Completely Rural 37 41 11 9 5 2
140321
Table 1.71B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 12.3 11.6 4.6 4.4 1.1 1.1
GEOGRAPHIC DIVISION            
Northeast 12.4 12.4 5.5 5.4 1.4 1.3
New England 13.4 13.5 5.7 7.0 1.9 1.2
Middle Atlantic 12.0 11.9 5.4 4.8 1.2 1.3
Midwest 10.7 10.3 2.9 3.6 0.8 0.9
East North Central 10.7 9.9 3.1 4.0 0.9 1.0
West North Central 10.6 11.4 2.6 2.8 0.5 0.7
South 11.7 10.4 4.1 3.4 1.1 0.9
South Atlantic 11.7 10.3 4.8 3.6 1.4 1.0
East South Central 9.6 9.2 2.9 2.7 1.0 0.6
West South Central 12.7 11.2 3.7 3.5 0.8 0.9
West 14.7 14.0 6.2 6.0 1.4 1.7
Mountain 17.4 15.3 6.2 4.8 1.6 1.6
Pacific 13.6 13.5 6.2 6.5 1.3 1.7
COUNTY TYPE            
Large Metro 12.8 11.8 5.3 4.7 1.3 1.2
Small Metro 12.0 11.2 4.2 4.5 1.0 1.2
250K - 1 Mil. Pop. 11.8 11.9 4.2 4.6 1.1 1.3
< 250K Pop. 12.3a 10.0 4.1 4.3 0.9 1.0
Nonmetro 11.1 12.0 2.9 3.3 0.7 0.7
Urbanized 12.3 13.3 3.2 4.4 0.8 0.7
Less Urbanized 10.6 11.2 2.7 2.4 0.5 0.6
Completely Rural 8.2 8.6 2.5 2.0 1.1 0.5
140321
Table 1.72A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 33,156 33,378 2,890 2,508 1,222 1,108
GEOGRAPHIC DIVISION            
Northeast 6,229 6,231 680 526 296 178
New England 2,014 1,856 141 190 83 56
Middle Atlantic 4,214 4,375 539a 336 213 122
Midwest 6,494 6,100 484 452 226 179
East North Central 4,799 4,328 389 377 176 144
West North Central 1,694 1,772 94 75 50 36
South 10,562 11,381 1,006 868 419 462
South Atlantic 5,965 6,394 637 576 265 337
East South Central 1,406 1,612 128 80 65 42
West South Central 3,191 3,374 242 212 89 83
West 9,872 9,665 721 662 282 289
Mountain 2,959 2,796 242 215 91 92
Pacific 6,913 6,870 479 447 190 197
COUNTY TYPE            
Large Metro 18,454 18,042 1,810 1,581 829 707
Small Metro 10,526 10,409 871 704 310 263
250K - 1 Mil. Pop. 7,242 7,233 656 538 210 211
< 250K Pop. 3,284 3,175 215 166 100 52
Nonmetro 4,177a 4,927 210 223 83 137
Urbanized 2,108 2,397 76 83 40 31
Less Urbanized 1,741 2,029 97 90 21 59
Completely Rural 328 501 37 49 23 47
140321
Table 1.72B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 16.5 16.5 1.4 1.2 0.6 0.5
GEOGRAPHIC DIVISION            
Northeast 16.9 16.8 1.8 1.4 0.8 0.5
New England 20.8 19.0 1.5 1.9 0.9 0.6
Middle Atlantic 15.6 16.0 2.0a 1.2 0.8 0.4
Midwest 15.0 14.1 1.1 1.0 0.5 0.4
East North Central 16.0 14.4 1.3 1.3 0.6 0.5
West North Central 12.9 13.3 0.7 0.6 0.4 0.3
South 14.2 15.1 1.4 1.2 0.6 0.6
South Atlantic 15.0 15.9 1.6 1.4 0.7 0.8
East South Central 11.8 13.5 1.1 0.7 0.5 0.3
West South Central 14.0 14.6 1.1 0.9 0.4 0.4
West 21.3 20.6 1.6 1.4 0.6 0.6
Mountain 21.0 19.6 1.7 1.5 0.6 0.6
Pacific 21.5 21.0 1.5 1.4 0.6 0.6
COUNTY TYPE            
Large Metro 17.3 16.6 1.7 1.5 0.8 0.7
Small Metro 17.5 17.2 1.4 1.2 0.5 0.4
250K - 1 Mil. Pop. 17.7 17.5 1.6 1.3 0.5 0.5
< 250K Pop. 16.9 16.5 1.1 0.9 0.5 0.3
Nonmetro 12.5a 14.8 0.6 0.7 0.2 0.4
Urbanized 14.6 16.1 0.5 0.6 0.3 0.2
Less Urbanized 11.5 13.5 0.6 0.6 0.1 0.4
Completely Rural 8.4a 14.1 0.9 1.4 0.6 1.3
140321
Table 1.73A – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 37,423 37,419 4,491 4,051 1,620 1,505
GEOGRAPHIC DIVISION            
Northeast 6,990 6,991 1,018 858 381 255
New England 2,231 2,076 233 303 113 76
Middle Atlantic 4,759 4,914 786a 554 268 179
Midwest 7,279 6,866 700 722 282 246
East North Central 5,343 4,832 546 583 221 194
West North Central 1,936 2,034 154 139 61 53
South 12,057 12,721 1,532 1,307 562 575
South Atlantic 6,730 7,069 947 811 353 400
East South Central 1,601 1,799 186 136 86 55
West South Central 3,725 3,853 399 361 123 120
West 11,097 10,840 1,240 1,164 395 429
Mountain 3,392 3,182 398 337 131 131
Pacific 7,705 7,658 842 827 265 298
COUNTY TYPE            
Large Metro 20,882 20,246 2,816 2,468 1,083 941
Small Metro 11,824 11,628 1,323 1,189 421 393
250K - 1 Mil. Pop. 8,056 8,066 947 858 286 302
< 250K Pop. 3,768 3,562 377 331 135 91
Nonmetro 4,717a 5,545 351 394 116 171
Urbanized 2,380 2,726 147 192 57 49
Less Urbanized 1,973 2,278 156 144 31 73
Completely Rural 364 542 48 59 28 49
140321
Table 1.73B – Cocaine Use in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Cocaine use includes the use of crack.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 15.9 15.8 1.9 1.7 0.7 0.6
GEOGRAPHIC DIVISION            
Northeast 16.3 16.2 2.4 2.0 0.9 0.6
New England 19.7 18.2 2.1 2.7 1.0 0.7
Middle Atlantic 15.0 15.4 2.5a 1.7 0.8 0.6
Midwest 14.4 13.5 1.4 1.4 0.6 0.5
East North Central 15.2 13.7 1.6 1.7 0.6 0.5
West North Central 12.5 13.0 1.0 0.9 0.4 0.3
South 13.8 14.4 1.8 1.5 0.6 0.7
South Atlantic 14.6 15.1 2.0 1.7 0.8 0.9
East South Central 11.5 12.8 1.3 1.0 0.6 0.4
West South Central 13.8 14.1 1.5 1.3 0.5 0.4
West 20.3 19.6 2.3 2.1 0.7 0.8
Mountain 20.5 18.9 2.4 2.0 0.8 0.8
Pacific 20.3 19.9 2.2 2.1 0.7 0.8
COUNTY TYPE            
Large Metro 16.6 15.9 2.2 1.9 0.9 0.7
Small Metro 16.6 16.3 1.9 1.7 0.6 0.6
250K - 1 Mil. Pop. 16.9 16.7 2.0 1.8 0.6 0.6
< 250K Pop. 16.2 15.4 1.6 1.4 0.6 0.4
Nonmetro 12.3a 14.4 0.9 1.0 0.3 0.4
Urbanized 14.3 15.7 0.9 1.1 0.3 0.3
Less Urbanized 11.4 13.2 0.9 0.8 0.2 0.4
Completely Rural 8.4a 13.5 1.1 1.5 0.6 1.2
140321
Table 1.74A – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 9,015 8,870 921a 632 443 377
GEOGRAPHIC DIVISION            
Northeast 1,331 1,229 177 100 86 66
New England 314 412 27 29 12 23
Middle Atlantic 1,017 818 150 71 74 42
Midwest 1,883 1,814 183 178 84 98
East North Central 1,334 1,204 163 153 77 80
West North Central 549 610 20 25 7 18
South 3,410 3,421 477a 254 241 146
South Atlantic 1,875 2,005 319 160 194 90
East South Central 544 579 47 44 37 33
West South Central 991 838 111 50 11 22
West 2,391 2,405 84 100 32 68
Mountain 839 781 54 50 26 36
Pacific 1,552 1,624 30 50 6 31
COUNTY TYPE            
Large Metro 4,605 4,435 504a 252 276 189
Small Metro 3,132 2,783 294 252 121 123
250K - 1 Mil. Pop. 2,052 1,993 185 208 102 101
< 250K Pop. 1,079 791 110 44 19 22
Nonmetro 1,279a 1,651 124 128 46 65
Urbanized 546 679 43 42 27 14
Less Urbanized 602 780 54 42 9 24
Completely Rural 131 193 27 44 10 28
140321
Table 1.74B – Crack Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 3.5 3.4 0.4a 0.2 0.2 0.1
GEOGRAPHIC DIVISION            
Northeast 2.8 2.6 0.4 0.2 0.2 0.1
New England 2.5 3.3 0.2 0.2 0.1 0.2
Middle Atlantic 2.9 2.3 0.4 0.2 0.2 0.1
Midwest 3.4 3.2 0.3 0.3 0.2 0.2
East North Central 3.4 3.1 0.4 0.4 0.2 0.2
West North Central 3.2 3.5 0.1 0.1 0.0 0.1
South 3.5 3.5 0.5a 0.3 0.3 0.1
South Atlantic 3.7 3.9 0.6 0.3 0.4 0.2
East South Central 3.5 3.7 0.3 0.3 0.2 0.2
West South Central 3.3 2.7 0.4 0.2 0.0 0.1
West 3.9 3.9 0.1 0.2 0.1 0.1
Mountain 4.6 4.2 0.3 0.3 0.1 0.2
Pacific 3.7 3.8 0.1 0.1 0.0 0.1
COUNTY TYPE            
Large Metro 3.3 3.1 0.4a 0.2 0.2 0.1
Small Metro 4.0 3.5 0.4 0.3 0.2 0.2
250K - 1 Mil. Pop. 3.9 3.7 0.3 0.4 0.2 0.2
< 250K Pop. 4.2 3.1 0.4 0.2 0.1 0.1
Nonmetro 3.0a 3.9 0.3 0.3 0.1 0.2
Urbanized 3.0 3.6 0.2 0.2 0.1 0.1
Less Urbanized 3.2 4.1 0.3 0.2 0.0 0.1
Completely Rural 2.7 4.3 0.6 1.0 0.2 0.6
140321
Table 1.75A – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 37,908 39,736 4,306 4,430 1,134 1,333
GEOGRAPHIC DIVISION            
Northeast 6,917 7,321 752 780 187 249
New England 2,421 2,263 208 224 58 43
Middle Atlantic 4,496 5,059 543 557 129 206
Midwest 7,707 7,966 708 831 217 171
East North Central 5,523 5,434 569 603 178 110
West North Central 2,185 2,532 138a 228 39 61
South 11,690 12,694 1,431 1,393 418 437
South Atlantic 6,668 7,192 904 834 299 271
East South Central 1,472 1,734 158 166 35 67
West South Central 3,551 3,767 369 393 84 99
West 11,593 11,756 1,416 1,425 311 476
Mountain 3,595 3,598 445 450 100 95
Pacific 7,998 8,158 971 976 211 381
COUNTY TYPE            
Large Metro 20,675 22,074 2,558 2,597 640 709
Small Metro 12,237 12,190 1,367 1,294 411 414
250K - 1 Mil. Pop. 8,508 8,460 869 922 263 304
< 250K Pop. 3,729 3,731 498 372 148 110
Nonmetro 4,996 5,472 382 539 82 210
Urbanized 2,587 2,760 192 334 35 140
Less Urbanized 2,001 2,263 149 159 35 43
Completely Rural 409 449 41 46 13 28
140321
Table 1.75B – Hallucinogen Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.6 15.1 1.7 1.7 0.4 0.5
GEOGRAPHIC DIVISION            
Northeast 14.7 15.4 1.6 1.6 0.4 0.5
New England 19.5 18.1 1.7 1.8 0.5 0.3
Middle Atlantic 12.9 14.5 1.6 1.6 0.4 0.6
Midwest 13.8 14.2 1.3 1.5 0.4 0.3
East North Central 14.2 13.9 1.5 1.5 0.5 0.3
West North Central 12.8 14.7 0.8a 1.3 0.2 0.4
South 12.1 13.0 1.5 1.4 0.4 0.4
South Atlantic 13.1 14.0 1.8 1.6 0.6 0.5
East South Central 9.6 11.2 1.0 1.1 0.2 0.4
West South Central 11.8 12.3 1.2 1.3 0.3 0.3
West 19.1 19.2 2.3 2.3 0.5 0.8
Mountain 19.5 19.2 2.4 2.4 0.5 0.5
Pacific 19.0 19.2 2.3 2.3 0.5 0.9
COUNTY TYPE            
Large Metro 14.8 15.7 1.8 1.8 0.5 0.5
Small Metro 15.6 15.5 1.7 1.6 0.5 0.5
250K - 1 Mil. Pop. 16.1 15.8 1.6 1.7 0.5 0.6
< 250K Pop. 14.6 14.6 1.9 1.5 0.6 0.4
Nonmetro 11.8 12.9 0.9 1.3 0.2 0.5
Urbanized 14.0 14.5 1.0 1.8 0.2 0.7
Less Urbanized 10.5 11.9 0.8 0.8 0.2 0.2
Completely Rural 8.6 10.1 0.9 1.0 0.3 0.6
140321
Table 1.76A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 21,095 21,068 1,693 1,533 493 496
GEOGRAPHIC DIVISION            
Northeast 3,892 4,135 266 247 43a 97
New England 1,200 1,162 73 64 11 20
Middle Atlantic 2,692 2,973 193 183 32a 77
Midwest 4,373 4,141 297 234 100 81
East North Central 3,182 2,902 221 181 71 71
West North Central 1,191 1,239 76 53 29 10
South 6,961 6,707 602 530 190 130
South Atlantic 4,039 3,748 350 320 100 71
East South Central 1,018 1,015 77 82 23 28
West South Central 1,905 1,945 175 128 68 31
West 5,867 6,085 528 522 160 187
Mountain 2,043 2,017 133 189 33 60
Pacific 3,824 4,068 395 332 126 127
COUNTY TYPE            
Large Metro 11,149 11,790 987 873 328 280
Small Metro 7,091 6,312 447 433 107 136
250K - 1 Mil. Pop. 4,719 4,526 313 294 67 76
< 250K Pop. 2,371a 1,786 134 138 40 61
Nonmetro 2,855 2,966 259 227 58 80
Urbanized 1,520 1,513 157 121 21 48
Less Urbanized 1,115 1,229 74 89 25 20
Completely Rural 220 224 28 17 12 11
140321
Table 1.76B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 8.1 8.0 0.7 0.6 0.2 0.2
GEOGRAPHIC DIVISION            
Northeast 8.3 8.7 0.6 0.5 0.1a 0.2
New England 9.7 9.3 0.6 0.5 0.1 0.2
Middle Atlantic 7.7 8.5 0.6 0.5 0.1a 0.2
Midwest 7.8 7.4 0.5 0.4 0.2 0.1
East North Central 8.2 7.4 0.6 0.5 0.2 0.2
West North Central 7.0 7.2 0.4 0.3 0.2 0.1
South 7.2 6.9 0.6 0.5 0.2 0.1
South Atlantic 7.9 7.3 0.7 0.6 0.2 0.1
East South Central 6.6 6.5 0.5 0.5 0.1 0.2
West South Central 6.3 6.4 0.6 0.4 0.2 0.1
West 9.7 9.9 0.9 0.9 0.3 0.3
Mountain 11.1 10.8 0.7 1.0 0.2 0.3
Pacific 9.1 9.6 0.9 0.8 0.3 0.3
COUNTY TYPE            
Large Metro 8.0 8.4 0.7 0.6 0.2 0.2
Small Metro 9.0a 8.0 0.6 0.5 0.1 0.2
250K - 1 Mil. Pop. 8.9 8.5 0.6 0.6 0.1 0.1
< 250K Pop. 9.3b 7.0 0.5 0.5 0.2 0.2
Nonmetro 6.8 7.0 0.6 0.5 0.1 0.2
Urbanized 8.2 8.0 0.8 0.6 0.1 0.3
Less Urbanized 5.9 6.5 0.4 0.5 0.1 0.1
Completely Rural 4.6 5.0 0.6 0.4 0.3 0.2
140321
Table 1.77A – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 1,613b 1,327 647b 480 188b 121
GEOGRAPHIC DIVISION            
Northeast 261b 163 87 71 15 18
New England 58 36 22 14 3 5
Middle Atlantic 203b 127 65 58 11 13
Midwest 347b 251 139a 98 42 25
East North Central 246b 176 103 77 29 19
West North Central 101 75 35 21 13 6
South 596 573 253 212 83 62
South Atlantic 301 291 129 109 31 36
East South Central 101 91 39 29 16a 4
West South Central 194 191 85 74 36 23
West 409 339 169b 99 48b 16
Mountain 126 110 46 40 15 7
Pacific 283 229 123b 59 33a 8
COUNTY TYPE            
Large Metro 865b 699 355b 256 106b 52
Small Metro 483 429 187 150 48 45
250K - 1 Mil. Pop. 318 275 127 99 33 26
< 250K Pop. 164 154 60 51 16 19
Nonmetro 265b 199 105a 74 34 24
Urbanized 119a 78 44 28 11 8
Less Urbanized 120 103 48 41 17 16
Completely Rural 27 18 13 5 6 0
140321
Table 1.77B – Inhalant Use in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 6.5b 5.3 2.6b 1.9 0.8b 0.5
GEOGRAPHIC DIVISION            
Northeast 6.1b 3.9 2.1 1.7 0.3 0.4
New England 5.2 3.3 2.0 1.2 0.3 0.4
Middle Atlantic 6.5b 4.1 2.1 1.9 0.4 0.4
Midwest 6.4b 4.7 2.6a 1.8 0.8 0.5
East North Central 6.5b 4.7 2.7 2.1 0.8 0.5
West North Central 6.2 4.6 2.2 1.3 0.8 0.3
South 6.4 6.1 2.7 2.3 0.9 0.7
South Atlantic 6.5 6.2 2.8 2.3 0.7 0.8
East South Central 6.8 6.2 2.7 1.9 1.1a 0.2
West South Central 6.1 5.9 2.7 2.3 1.1 0.7
West 6.8 5.7 2.8b 1.7 0.8b 0.3
Mountain 6.8 5.9 2.5 2.1 0.8 0.4
Pacific 6.9 5.6 3.0b 1.4 0.8a 0.2
COUNTY TYPE            
Large Metro 6.4b 5.2 2.6b 1.9 0.8b 0.4
Small Metro 6.5 5.8 2.5 2.0 0.7 0.6
250K - 1 Mil. Pop. 6.2 5.4 2.5 1.9 0.6 0.5
< 250K Pop. 7.1 6.6 2.6 2.2 0.7 0.8
Nonmetro 6.8b 5.1 2.7a 1.9 0.9 0.6
Urbanized 6.5a 4.7 2.4 1.7 0.6 0.5
Less Urbanized 7.1 5.8 2.9 2.3 1.0 0.9
Completely Rural 6.4 4.1 3.1 1.1 1.4 0.1
140321
Table 1.78A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 54,389 53,172 16,666a 15,348 6,831 6,484
GEOGRAPHIC DIVISION            
Northeast 9,116 8,415 2,738 2,424 1,055 915
New England 2,599 2,486 686 641 277 197
Middle Atlantic 6,517 5,929 2,052 1,783 778 719
Midwest 11,045 10,627 3,372 3,002 1,302 1,275
East North Central 8,059a 7,199 2,484 2,163 1,039 921
West North Central 2,986 3,428 887 839 263 354
South 19,039 19,315 6,075 5,874 2,661 2,528
South Atlantic 9,991 10,455 2,911 3,197 1,249 1,263
East South Central 2,954 2,908 1,058 906 492 456
West South Central 6,094 5,952 2,106 1,770 919 810
West 15,189 14,814 4,481 4,048 1,812 1,765
Mountain 4,630 4,450 1,354 1,272 540 464
Pacific 10,559 10,364 3,127 2,776 1,273 1,301
COUNTY TYPE            
Large Metro 30,081 28,830 9,421a 8,342 3,871 3,526
Small Metro 16,870 16,499 4,990 4,722 2,121 2,104
250K - 1 Mil. Pop. 11,547 11,325 3,377 3,047 1,493 1,391
< 250K Pop. 5,324 5,174 1,612 1,675 628 713
Nonmetro 7,438 7,844 2,256 2,284 839 853
Urbanized 3,645 3,881 1,062 1,127 394 397
Less Urbanized 3,084 3,286 1,010 975 378 383
Completely Rural 709 677 184 182 66 74
140321
Table 1.78B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 20.9 20.3 6.4a 5.8 2.6 2.5
GEOGRAPHIC DIVISION            
Northeast 19.3 17.8 5.8 5.1 2.2 1.9
New England 20.9 19.9 5.5 5.1 2.2 1.6
Middle Atlantic 18.7 17.0 5.9 5.1 2.2 2.1
Midwest 19.8 18.9 6.0 5.3 2.3 2.3
East North Central 20.8b 18.5 6.4 5.5 2.7 2.4
West North Central 17.5 19.9 5.2 4.9 1.5 2.1
South 19.8 19.8 6.3 6.0 2.8 2.6
South Atlantic 19.6 20.3 5.7 6.2 2.5 2.5
East South Central 19.2 18.8 6.9 5.8 3.2 2.9
West South Central 20.2 19.5 7.0a 5.8 3.1 2.6
West 25.1 24.2 7.4 6.6 3.0 2.9
Mountain 25.1 23.8 7.3 6.8 2.9 2.5
Pacific 25.0 24.3 7.4 6.5 3.0 3.1
COUNTY TYPE            
Large Metro 21.6 20.4 6.8b 5.9 2.8 2.5
Small Metro 21.5 20.9 6.4 6.0 2.7 2.7
250K - 1 Mil. Pop. 21.8 21.2 6.4 5.7 2.8 2.6
< 250K Pop. 20.8 20.3 6.3 6.6 2.5 2.8
Nonmetro 17.6 18.5 5.3 5.4 2.0 2.0
Urbanized 19.7 20.4 5.7 5.9 2.1 2.1
Less Urbanized 16.2 17.3 5.3 5.1 2.0 2.0
Completely Rural 14.9 15.2 3.9 4.1 1.4 1.7
140321
Table 1.79A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 2,482b 2,188 1,642b 1,441 693b 549
GEOGRAPHIC DIVISION            
Northeast 324 272 215 192 84 64
New England 74 70 55 51 23 18
Middle Atlantic 250 202 160 141 61 46
Midwest 510a 441 356a 285 147 118
East North Central 374b 304 256a 195 107 81
West North Central 136 137 100 90 40 37
South 984a 864 638 553 287a 213
South Atlantic 455 401 296 264 136 96
East South Central 164 141 109 91 45 30
West South Central 366 323 233 198 105 87
West 664 611 433 411 175 154
Mountain 229 197 166 137 67a 40
Pacific 435 414 267 274 108 114
COUNTY TYPE            
Large Metro 1,248 1,106 841 752 351 280
Small Metro 800 717 528 478 226 183
250K - 1 Mil. Pop. 537 472 364 308 157a 116
< 250K Pop. 263 245 164 171 69 67
Nonmetro 433a 364 272b 211 116 86
Urbanized 217a 163 123 103 54 40
Less Urbanized 175 164 114 87 48 41
Completely Rural 41 37 35a 21 14 5
140321
Table 1.79B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 10.0b 8.8 6.6b 5.8 2.8b 2.2
GEOGRAPHIC DIVISION            
Northeast 7.6 6.5 5.1 4.6 2.0 1.5
New England 6.7 6.4 4.9 4.6 2.1 1.6
Middle Atlantic 8.0 6.5 5.1 4.6 1.9 1.5
Midwest 9.4a 8.2 6.6a 5.3 2.7 2.2
East North Central 9.9a 8.1 6.8a 5.2 2.8 2.1
West North Central 8.3 8.3 6.1 5.5 2.4 2.3
South 10.6a 9.2 6.9a 5.9 3.1a 2.3
South Atlantic 9.8 8.6 6.4 5.7 2.9 2.1
East South Central 11.1 9.6 7.4 6.2 3.1 2.1
West South Central 11.5 10.0 7.3 6.1 3.3 2.7
West 11.1 10.3 7.3 6.9 2.9 2.6
Mountain 12.3 10.5 8.9 7.3 3.6a 2.1
Pacific 10.6 10.2 6.5 6.7 2.6 2.8
COUNTY TYPE            
Large Metro 9.2a 8.2 6.2 5.5 2.6 2.1
Small Metro 10.8 9.6 7.1 6.4 3.1 2.5
250K - 1 Mil. Pop. 10.5 9.2 7.1 6.0 3.1a 2.3
< 250K Pop. 11.4 10.5 7.1 7.3 3.0 2.9
Nonmetro 11.1a 9.4 6.9a 5.4 3.0 2.2
Urbanized 12.0 9.8 6.8 6.2 3.0 2.4
Less Urbanized 10.3 9.2 6.7a 4.9 2.9 2.3
Completely Rural 10.0 8.4 8.4a 4.7 3.3a 1.1
140321
Table 1.80A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 9,709a 9,239 4,729b 4,245 1,832 1,661
GEOGRAPHIC DIVISION            
Northeast 1,637 1,522 876 780 362 279
New England 480 414 238 253 101 72
Middle Atlantic 1,157 1,108 638a 527 261 208
Midwest 2,072 1,970 969 900 338 380
East North Central 1,448 1,328 687 636 265 263
West North Central 624 642 283 264 72a 118
South 3,541 3,355 1,693 1,523 694 615
South Atlantic 1,782 1,648 876 788 351 293
East South Central 540 549 257 242 124 117
West South Central 1,220 1,158 561 493 219 205
West 2,459 2,392 1,190 1,042 438 387
Mountain 777 746 342 303 133 118
Pacific 1,682 1,645 848 738 305 268
COUNTY TYPE            
Large Metro 5,352 4,978 2,687b 2,283 1,056 895
Small Metro 3,074 2,874 1,490 1,353 554 522
250K - 1 Mil. Pop. 1,940 1,808 932 861 357 330
< 250K Pop. 1,134 1,066 558 492 197 192
Nonmetro 1,283 1,387 552 609 223 244
Urbanized 618 691 242 312 91 127
Less Urbanized 554 591 259 254 115 112
Completely Rural 111 105 51 43 16 6
140321
Table 1.80B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 28.1a 26.6 13.7b 12.2 5.3 4.8
GEOGRAPHIC DIVISION            
Northeast 26.6 24.8 14.2 12.7 5.9 4.5
New England 29.6 25.4 14.7 15.5 6.2 4.4
Middle Atlantic 25.5 24.5 14.1a 11.7 5.8 4.6
Midwest 28.1 26.6 13.2 12.1 4.6 5.1
East North Central 28.5 26.0 13.5 12.5 5.2 5.1
West North Central 27.3 27.9 12.4 11.5 3.2a 5.1
South 27.8 26.1 13.3a 11.8 5.4 4.8
South Atlantic 27.3 25.1 13.4 12.0 5.4 4.5
East South Central 26.7 26.9 12.7 11.9 6.1 5.7
West South Central 29.0 27.2 13.3 11.6 5.2 4.8
West 29.6 28.6 14.3 12.4 5.3 4.6
Mountain 31.1 29.5 13.7 12.0 5.4 4.7
Pacific 28.9 28.2 14.6 12.6 5.2 4.6
COUNTY TYPE            
Large Metro 28.3 26.6 14.2b 12.2 5.6 4.8
Small Metro 28.4a 26.4 13.8 12.4 5.1 4.8
250K - 1 Mil. Pop. 28.2 25.9 13.5 12.3 5.2 4.7
< 250K Pop. 28.9 27.5 14.2 12.7 5.0 4.9
Nonmetro 26.5 26.8 11.4 11.8 4.6 4.7
Urbanized 27.8 28.0 10.9 12.6 4.1 5.1
Less Urbanized 25.4 26.6 11.9 11.4 5.3 5.0
Completely Rural 24.9 22.1 11.4 9.0 3.6 1.2
140321
Table 1.81A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 42,198 41,745 10,296 9,662 4,306 4,274
GEOGRAPHIC DIVISION            
Northeast 7,155 6,622 1,647 1,452 609 572
New England 2,045 2,002 393 337 152 108
Middle Atlantic 5,110 4,620 1,254 1,115 457 465
Midwest 8,463 8,217 2,046 1,817 818 777
East North Central 6,236a 5,567 1,542 1,332 667 578
West North Central 2,227 2,650 504 485 151 199
South 14,514 15,095 3,744 3,798 1,679 1,700
South Atlantic 7,755 8,406 1,739 2,146 762 874
East South Central 2,251 2,219 693 573 322 309
West South Central 4,509 4,471 1,313 1,079 595 518
West 12,067 11,812 2,858 2,595 1,199 1,225
Mountain 3,625 3,507 846 832 339 306
Pacific 8,442 8,304 2,012 1,763 860 919
COUNTY TYPE            
Large Metro 23,480 22,746 5,892 5,307 2,465 2,352
Small Metro 12,997 12,907 2,972 2,891 1,341 1,399
250K - 1 Mil. Pop. 9,070 9,044 2,082 1,879 979 945
< 250K Pop. 3,927 3,863 890 1,013 362 454
Nonmetro 5,722 6,093 1,433 1,464 500 523
Urbanized 2,809 3,026 697 711 249 230
Less Urbanized 2,356 2,531 637 634 215 230
Completely Rural 557 535 99 118 36 63
140321
Table 1.81B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 21.0 20.6 5.1 4.8 2.1 2.1
GEOGRAPHIC DIVISION            
Northeast 19.5 17.9 4.5 3.9 1.7 1.5
New England 21.1 20.5 4.1 3.5 1.6 1.1
Middle Atlantic 18.9 16.9 4.6 4.1 1.7 1.7
Midwest 19.6 18.9 4.7 4.2 1.9 1.8
East North Central 20.8a 18.5 5.1 4.4 2.2 1.9
West North Central 16.9 19.9 3.8 3.6 1.1 1.5
South 19.5 20.0 5.0 5.0 2.3 2.3
South Atlantic 19.5 20.9 4.4 5.3 1.9 2.2
East South Central 18.9 18.5 5.8 4.8 2.7 2.6
West South Central 19.8 19.4 5.8 4.7 2.6 2.2
West 26.1 25.2 6.2 5.5 2.6 2.6
Mountain 25.8 24.5 6.0 5.8 2.4 2.1
Pacific 26.2 25.4 6.2 5.4 2.7 2.8
COUNTY TYPE            
Large Metro 22.0 20.9 5.5 4.9 2.3 2.2
Small Metro 21.6 21.3 4.9 4.8 2.2 2.3
250K - 1 Mil. Pop. 22.2 21.9 5.1 4.6 2.4 2.3
< 250K Pop. 20.3 20.0 4.6 5.2 1.9 2.4
Nonmetro 17.1 18.2 4.3 4.4 1.5 1.6
Urbanized 19.4 20.4 4.8 4.8 1.7 1.5
Less Urbanized 15.6 16.9 4.2 4.2 1.4 1.5
Completely Rural 14.3 15.1 2.5 3.3 0.9 1.8
140321
Table 1.82A – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 51,908 50,984 15,025 13,907 6,138 5,935
GEOGRAPHIC DIVISION            
Northeast 8,792 8,144 2,523 2,232 971 851
New England 2,525 2,416 631 591 254 179
Middle Atlantic 6,267 5,728 1,892 1,642 718 672
Midwest 10,535 10,186 3,016 2,717 1,156 1,157
East North Central 7,685a 6,895 2,229 1,968 932 840
West North Central 2,850 3,292 787 749 224 317
South 18,055 18,451 5,438 5,321 2,374 2,316
South Atlantic 9,536 10,054 2,615 2,933 1,113 1,167
East South Central 2,791 2,767 950 815 447 426
West South Central 5,728 5,629 1,873 1,572 814 723
West 14,525 14,203 4,048 3,637 1,637 1,612
Mountain 4,401 4,254 1,188 1,135 472 425
Pacific 10,124 9,949 2,860 2,502 1,165 1,187
COUNTY TYPE            
Large Metro 28,833 27,723 8,579a 7,590 3,520 3,247
Small Metro 16,070 15,781 4,461 4,244 1,895 1,921
250K - 1 Mil. Pop. 11,010 10,853 3,013 2,739 1,336 1,275
< 250K Pop. 5,061 4,929 1,448 1,505 559 646
Nonmetro 7,005 7,479 1,984 2,073 723 768
Urbanized 3,427 3,718 939 1,024 340 357
Less Urbanized 2,909 3,122 896 888 330 342
Completely Rural 668 640 150 161 53 69
140321
Table 1.82B – Nonmedical Use of Prescription-Type Psychotherapeutics in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
NOTE: Nonmedical use of prescription-type psychotherapeutics includes the nonmedical use of pain relievers, tranquilizers, stimulants, or sedatives and does not include over-the-counter drugs.
NOTE: Estimates in this table include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 22.1 21.5 6.4a 5.9 2.6 2.5
GEOGRAPHIC DIVISION            
Northeast 20.5 18.9 5.9 5.2 2.3 2.0
New England 22.3 21.2 5.6 5.2 2.2 1.6
Middle Atlantic 19.8 18.0 6.0 5.2 2.3 2.1
Midwest 20.9 20.0 6.0 5.3 2.3 2.3
East North Central 21.9a 19.6 6.4 5.6 2.7 2.4
West North Central 18.4 21.1 5.1 4.8 1.4 2.0
South 20.7 20.9 6.2 6.0 2.7 2.6
South Atlantic 20.6 21.5 5.7 6.3 2.4 2.5
East South Central 20.0 19.7 6.8 5.8 3.2 3.0
West South Central 21.3 20.6 7.0 5.8 3.0 2.6
West 26.6 25.7 7.4 6.6 3.0 2.9
Mountain 26.6 25.3 7.2 6.7 2.9 2.5
Pacific 26.6 25.8 7.5 6.5 3.1 3.1
COUNTY TYPE            
Large Metro 22.9 21.7 6.8a 6.0 2.8 2.5
Small Metro 22.6 22.1 6.3 5.9 2.7 2.7
250K - 1 Mil. Pop. 23.0 22.5 6.3 5.7 2.8 2.6
< 250K Pop. 21.7 21.3 6.2 6.5 2.4 2.8
Nonmetro 18.3 19.4 5.2 5.4 1.9 2.0
Urbanized 20.6 21.4 5.6 5.9 2.0 2.1
Less Urbanized 16.8 18.1 5.2 5.2 1.9 2.0
Completely Rural 15.3 15.9 3.4 4.0 1.2 1.7
140321
Table 1.83A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 37,045 35,473 12,489b 11,082 4,862 4,521
GEOGRAPHIC DIVISION            
Northeast 6,090b 5,164 1,930a 1,569 772 643
New England 1,748 1,530 459 393 197a 115
Middle Atlantic 4,342b 3,634 1,471a 1,176 575 528
Midwest 7,712 7,182 2,591a 2,153 1,025 879
East North Central 5,721b 5,031 1,970b 1,557 818a 644
West North Central 1,990 2,151 621 596 207 235
South 13,056 13,149 4,583 4,276 1,893 1,777
South Atlantic 6,637 7,065 2,284 2,282 946 877
East South Central 2,310 2,073 817 712 354 368
West South Central 4,109 4,011 1,481 1,282 593 532
West 10,187 9,979 3,386 3,084 1,172 1,222
Mountain 2,994 3,117 925 989 348 280
Pacific 7,193 6,862 2,461 2,095 823 942
COUNTY TYPE            
Large Metro 20,563 19,343 7,042b 5,952 2,737 2,473
Small Metro 11,341 10,810 3,720 3,371 1,481 1,486
250K - 1 Mil. Pop. 7,679 7,379 2,488 2,231 1,009 1,008
< 250K Pop. 3,663 3,431 1,232 1,139 472 478
Nonmetro 5,141 5,320 1,727 1,759 644 563
Urbanized 2,599 2,646 843 916 266 259
Less Urbanized 2,086 2,242 743 700 320 238
Completely Rural 456 432 142 143 58 66
140321
Table 1.83B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.2a 13.5 4.8b 4.2 1.9 1.7
GEOGRAPHIC DIVISION            
Northeast 12.9b 10.9 4.1a 3.3 1.6 1.4
New England 14.1 12.3 3.7 3.1 1.6a 0.9
Middle Atlantic 12.5b 10.4 4.2a 3.4 1.7 1.5
Midwest 13.8 12.8 4.6a 3.8 1.8 1.6
East North Central 14.7b 12.9 5.1b 4.0 2.1a 1.7
West North Central 11.6 12.5 3.6 3.5 1.2 1.4
South 13.5 13.5 4.8 4.4 2.0 1.8
South Atlantic 13.1 13.7 4.5 4.4 1.9 1.7
East South Central 15.0 13.4 5.3 4.6 2.3 2.4
West South Central 13.6 13.1 4.9 4.2 2.0 1.7
West 16.8 16.3 5.6 5.0 1.9 2.0
Mountain 16.3 16.7 5.0 5.3 1.9 1.5
Pacific 17.1 16.1 5.8 4.9 2.0 2.2
COUNTY TYPE            
Large Metro 14.8a 13.7 5.1b 4.2 2.0 1.8
Small Metro 14.4 13.7 4.7 4.3 1.9 1.9
250K - 1 Mil. Pop. 14.5 13.8 4.7 4.2 1.9 1.9
< 250K Pop. 14.3 13.4 4.8 4.5 1.8 1.9
Nonmetro 12.2 12.5 4.1 4.1 1.5 1.3
Urbanized 14.1 13.9 4.6 4.8 1.4 1.4
Less Urbanized 11.0 11.8 3.9 3.7 1.7 1.3
Completely Rural 9.6 9.7 3.0 3.2 1.2 1.5
140321
Table 1.84A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 2,069b 1,805 1,333b 1,157 558b 425
GEOGRAPHIC DIVISION            
Northeast 255 206 166 135 66 48
New England 62 50 43 35 20 15
Middle Atlantic 193 156 123 100 46 33
Midwest 429a 365 288a 230 118a 85
East North Central 318a 258 212a 160 87a 61
West North Central 110 107 76 70 32 24
South 814 714 506 452 226a 171
South Atlantic 373 334 232 214 103 79
East South Central 140 108 88 68 39 26
West South Central 301 272 186 170 84 66
West 571 520 373 340 148 121
Mountain 192 163 145 114 58b 27
Pacific 379 357 227 226 89 94
COUNTY TYPE            
Large Metro 1,033a 898 678 596 275 213
Small Metro 677 596 436 382 186a 139
250K - 1 Mil. Pop. 461 394 301 241 127a 84
< 250K Pop. 216 202 135 141 59 55
Nonmetro 358 312 219 179 97 73
Urbanized 174 141 95 87 44 33
Less Urbanized 151 139 98 76 44 37
Completely Rural 33 31 27 16 9 2
140321
Table 1.84B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 12 to 17, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 8.3b 7.3 5.3b 4.6 2.2b 1.7
GEOGRAPHIC DIVISION            
Northeast 6.0 4.9 3.9 3.2 1.6 1.2
New England 5.6 4.6 3.9 3.2 1.8 1.4
Middle Atlantic 6.2 5.1 3.9 3.2 1.5 1.1
Midwest 7.9a 6.8 5.3a 4.3 2.2a 1.6
East North Central 8.4a 6.9 5.6a 4.3 2.3 1.6
West North Central 6.7 6.5 4.6 4.3 1.9 1.5
South 8.7 7.6 5.4 4.8 2.4a 1.8
South Atlantic 8.0 7.2 5.0 4.6 2.2 1.7
East South Central 9.4 7.3 6.0 4.6 2.6 1.8
West South Central 9.5 8.4 5.8 5.3 2.6 2.0
West 9.6 8.7 6.2 5.7 2.5 2.0
Mountain 10.3 8.7 7.8 6.1 3.1b 1.5
Pacific 9.2 8.8 5.5 5.5 2.2 2.3
COUNTY TYPE            
Large Metro 7.6a 6.6 5.0 4.4 2.0 1.6
Small Metro 9.1 8.0 5.9 5.1 2.5a 1.9
250K - 1 Mil. Pop. 9.0 7.7 5.9a 4.7 2.5a 1.6
< 250K Pop. 9.4 8.7 5.9 6.0 2.6 2.4
Nonmetro 9.1 8.0 5.6 4.6 2.5 1.9
Urbanized 9.6 8.5 5.2 5.2 2.4 2.0
Less Urbanized 8.9 7.8 5.8 4.3 2.6 2.1
Completely Rural 7.9 7.0 6.4 3.5 2.2 0.5
140321
Table 1.85A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 7,759b 7,251 3,507b 3,061 1,311a 1,132
GEOGRAPHIC DIVISION            
Northeast 1,254a 1,095 581 499 250 189
New England 371a 266 147 143 66a 36
Middle Atlantic 884 829 434 356 183 154
Midwest 1,611 1,563 716 640 255 232
East North Central 1,168a 1,043 529a 438 208a 154
West North Central 443 520 188 201 47a 78
South 2,841 2,643 1,297a 1,120 496 419
South Atlantic 1,402 1,273 653 556 258 195
East South Central 477 459 214 182 89 79
West South Central 962 911 429 382 149 146
West 2,052 1,950 913 801 311 291
Mountain 660 596 267 224 98 77
Pacific 1,392 1,353 645 578 213 214
COUNTY TYPE            
Large Metro 4,239a 3,827 1,960b 1,626 762a 611
Small Metro 2,449 2,291 1,111 990 376 361
250K - 1 Mil. Pop. 1,545 1,462 707 650 244 237
< 250K Pop. 904 829 404 340 133 124
Nonmetro 1,071 1,133 436 445 172 160
Urbanized 506 564 189 236 69 82
Less Urbanized 471 493 207 176 92 72
Completely Rural 94 75 40 33 12 5
140321
Table 1.85B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 to 25, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 22.4b 20.8 10.1b 8.8 3.8a 3.3
GEOGRAPHIC DIVISION            
Northeast 20.4a 17.8 9.4 8.1 4.1 3.1
New England 22.9a 16.3 9.1 8.8 4.1a 2.2
Middle Atlantic 19.5 18.4 9.6 7.9 4.0 3.4
Midwest 21.9 21.1 9.7 8.6 3.5 3.1
East North Central 23.0a 20.4 10.4a 8.6 4.1a 3.0
West North Central 19.4 22.6 8.2 8.7 2.0a 3.4
South 22.3a 20.6 10.2a 8.7 3.9 3.3
South Atlantic 21.5 19.4 10.0 8.5 3.9 3.0
East South Central 23.6 22.5 10.6 8.9 4.4 3.9
West South Central 22.8 21.4 10.2 9.0 3.6 3.4
West 24.7 23.3 11.0 9.6 3.7 3.5
Mountain 26.5 23.6 10.7 8.8 3.9 3.0
Pacific 23.9 23.2 11.1 9.9 3.7 3.7
COUNTY TYPE            
Large Metro 22.4a 20.4 10.4b 8.7 4.0a 3.3
Small Metro 22.7 21.1 10.3 9.1 3.5 3.3
250K - 1 Mil. Pop. 22.4 20.9 10.3 9.3 3.5 3.4
< 250K Pop. 23.1 21.4 10.3 8.8 3.4 3.2
Nonmetro 22.1 21.9 9.0 8.6 3.6 3.1
Urbanized 22.8 22.8 8.5 9.6 3.1 3.3
Less Urbanized 21.6 22.2 9.5 7.9 4.2 3.3
Completely Rural 21.0 15.9 9.0 6.9 2.6 1.1
140321
Table 1.86A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 27,218 26,417 7,649 6,865 2,993 2,964
GEOGRAPHIC DIVISION            
Northeast 4,581a 3,862 1,182 934 457 406
New England 1,316 1,214 268 214 111 64
Middle Atlantic 3,265a 2,648 914 719 346 342
Midwest 5,672 5,254 1,587 1,283 652 562
East North Central 4,235a 3,730 1,229 958 523 430
West North Central 1,437 1,524 358 325 128 132
South 9,402 9,792 2,780 2,704 1,171 1,187
South Atlantic 4,863 5,457 1,399 1,513 586 603
East South Central 1,693 1,506 514 462 227 263
West South Central 2,846 2,828 866 730 359 321
West 7,564 7,509 2,100 1,943 713 810
Mountain 2,142 2,358 512 651 192 176
Pacific 5,421 5,151 1,588 1,292 521 634
COUNTY TYPE            
Large Metro 15,291 14,619 4,405 3,730 1,700 1,648
Small Metro 8,215 7,923 2,172 1,999 919 986
250K - 1 Mil. Pop. 5,673 5,523 1,480 1,340 639 687
< 250K Pop. 2,542 2,400 692 659 280 299
Nonmetro 3,712 3,875 1,072 1,135 375 330
Urbanized 1,918 1,940 559 593 153 144
Less Urbanized 1,464 1,609 438 448 185 128
Completely Rural 329 325 75 95 36 58
140321
Table 1.86B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 26 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 13.6 13.0 3.8 3.4 1.5 1.5
GEOGRAPHIC DIVISION            
Northeast 12.5a 10.4 3.2 2.5 1.2 1.1
New England 13.6 12.4 2.8 2.2 1.1 0.7
Middle Atlantic 12.0a 9.7 3.4 2.6 1.3 1.3
Midwest 13.1 12.1 3.7 3.0 1.5 1.3
East North Central 14.1a 12.4 4.1 3.2 1.7 1.4
West North Central 10.9 11.5 2.7 2.4 1.0 1.0
South 12.7 13.0 3.7 3.6 1.6 1.6
South Atlantic 12.3 13.6 3.5 3.8 1.5 1.5
East South Central 14.2 12.6 4.3 3.9 1.9 2.2
West South Central 12.5 12.3 3.8 3.2 1.6 1.4
West 16.3 16.0 4.5 4.1 1.5 1.7
Mountain 15.2 16.5 3.6 4.6 1.4 1.2
Pacific 16.8 15.8 4.9 4.0 1.6 1.9
COUNTY TYPE            
Large Metro 14.3 13.4 4.1a 3.4 1.6 1.5
Small Metro 13.6 13.1 3.6 3.3 1.5 1.6
250K - 1 Mil. Pop. 13.9 13.4 3.6 3.2 1.6 1.7
< 250K Pop. 13.1 12.4 3.6 3.4 1.4 1.5
Nonmetro 11.1 11.6 3.2 3.4 1.1 1.0
Urbanized 13.3 13.1 3.9 4.0 1.1 1.0
Less Urbanized 9.7 10.7 2.9 3.0 1.2 0.9
Completely Rural 8.4 9.2 1.9 2.7 0.9 1.6
140321
Table 1.87A – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Numbers in Thousands, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 34,977 33,668 11,157a 9,925 4,304 4,096
GEOGRAPHIC DIVISION            
Northeast 5,835b 4,957 1,763a 1,433 706 595
New England 1,686 1,480 415 358 177a 100
Middle Atlantic 4,149a 3,477 1,348 1,075 529 495
Midwest 7,283 6,817 2,303a 1,923 906 794
East North Central 5,403a 4,773 1,758a 1,396 731 583
West North Central 1,880 2,044 545 527 175 211
South 12,242 12,435 4,077 3,825 1,667 1,606
South Atlantic 6,264 6,731 2,052 2,069 843 798
East South Central 2,170 1,965 729 644 315 341
West South Central 3,808 3,739 1,296 1,112 508 466
West 9,616 9,459 3,013 2,744 1,024 1,101
Mountain 2,802 2,954 780 875 290 253
Pacific 6,814 6,505 2,233 1,869 734 848
COUNTY TYPE            
Large Metro 19,530 18,445 6,365b 5,356 2,462 2,259
Small Metro 10,664 10,214 3,284 2,989 1,295 1,347
250K - 1 Mil. Pop. 7,218 6,984 2,187 1,990 882 924
< 250K Pop. 3,447 3,229 1,097 999 413 423
Nonmetro 4,783 5,009 1,508 1,580 547 490
Urbanized 2,424 2,505 748 829 222 226
Less Urbanized 1,935 2,103 645 623 277 201
Completely Rural 423 401 115 128 48 63
140321
Table 1.87B – Nonmedical Use of Pain Relievers in Lifetime, Past Year, and Past Month among Persons Aged 18 or Older, by Geographic Characteristics: Percentages, 2012 and 2013
Geographic Characteristic Lifetime
(2012)
Lifetime
(2013)
Past Year
(2012)
Past Year
(2013)
Past Month
(2012)
Past Month
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
TOTAL 14.9 14.2 4.7b 4.2 1.8 1.7
GEOGRAPHIC DIVISION            
Northeast 13.6b 11.5 4.1a 3.3 1.6 1.4
New England 14.9 13.0 3.7 3.1 1.6a 0.9
Middle Atlantic 13.1a 10.9 4.3 3.4 1.7 1.6
Midwest 14.4 13.4 4.6a 3.8 1.8 1.6
East North Central 15.4b 13.6 5.0a 4.0 2.1 1.7
West North Central 12.2 13.1 3.5 3.4 1.1 1.4
South 14.1 14.1 4.7 4.3 1.9 1.8
South Atlantic 13.6 14.4 4.4 4.4 1.8 1.7
East South Central 15.6 14.0 5.2 4.6 2.3 2.4
West South Central 14.1 13.7 4.8 4.1 1.9 1.7
West 17.6 17.1 5.5 5.0 1.9 2.0
Mountain 16.9 17.6 4.7 5.2 1.8 1.5
Pacific 17.9 16.9 5.9 4.9 1.9 2.2
COUNTY TYPE            
Large Metro 15.5a 14.5 5.1b 4.2 2.0 1.8
Small Metro 15.0 14.3 4.6 4.2 1.8 1.9
250K - 1 Mil. Pop. 15.1 14.5 4.6 4.1 1.8 1.9
< 250K Pop. 14.8 13.9 4.7 4.3 1.8 1.8
Nonmetro 12.5 13.0 3.9 4.1 1.4 1.3
Urbanized 14.5 14.4 4.5 4.8 1.3 1.3
Less Urbanized 11.2 12.2 3.7 3.6 1.6 1.2
Completely Rural 9.7 10.0 2.6 3.2 1.1 1.6
140324
Table 1.88A – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Numbers in Thousands, 2012 and 2013
Drug or Method of Administration Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
HALLUCINOGENS 37,908 39,736 823a 702 6,103 6,122 30,982a 32,912
PCP (Angel Dust, Phencyclidine) 6,552 6,462 96b 46 345 326 6,112 6,090
LSD (Acid) 23,735 24,770 249 221 2,056 2,246 21,430 22,303
Peyote 5,925 5,759 48 37 316 332 5,561 5,390
Mescaline 7,891 8,116 28 23 336 324 7,527 7,769
Psilocybin (Mushrooms) 20,989a 22,850 319 295 3,226 3,347 17,445a 19,209
Ecstasy (MDMA) 16,162b 17,815 488b 369 4,452 4,436 11,222b 13,009
INHALANTS 21,095 21,068 1,613b 1,327 2,918b 2,613 16,563 17,129
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 6,729 7,384 228 176 498 521 6,002 6,687
Correction Fluid, Degreaser, or Cleaning Fluid 1,709 1,350 332 277 238 216 1,139 857
Gasoline or Lighter Fluid 3,375b 2,686 535b 397 455b 325 2,385 1,965
Glue, Shoe Polish, or Toluene 3,118 2,882 582a 471 378 353 2,158 2,059
Halothane, Ether, or Other Anesthetics 858 803 44 50 112 99 702 653
Lacquer Thinner or Other Paint Solvents 1,559 1,359 245b 171 202 183 1,113 1,005
Lighter Gases (Butane, Propane) 771 758 156a 110 100 109 515 539
Nitrous Oxide or Whippits 12,139 12,368 189 156 1,812b 1,529 10,138 10,683
Spray Paints 1,755 1,662 532b 355 301 292 922 1,015
Other Aerosol Sprays 2,113 1,979 321a 244 494 483 1,299 1,252
NEEDLE USE1,2,3 4,039 4,442 47 48 466 473 3,526 3,920
Heroin Needle Use1,2 2,079 2,555 21 19 292 322 1,767 2,213
Cocaine Needle Use1,2 2,027 2,287 6 2 154 157 1,867 2,128
Stimulant Needle Use1,2,3 1,821a 2,347 16 15 160 195 1,646a 2,137
Methamphetamine Needle Use1,2,3 1,589 1,891 11 14 130 144 1,448 1,733
HEROIN 4,565 4,812 59 38 664 619 3,841 4,155
Smoke Heroin2 1,760 1,650 27 15 320 295 1,412 1,341
Sniff or Snort Heroin2 3,276 3,257 18 14 467 437 2,790 2,806
140324
Table 1.88B – Specific Hallucinogen, Inhalant, Needle, and Heroin Use in Lifetime, by Age Group: Percentages, 2012 and 2013
Drug or Method of Administration Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Refers to lifetime use of a needle to inject a drug that was not prescribed, or that was taken only for the experience or feeling it caused.
2 These drug estimates are generated from data collected on a "noncore" module of the NSDUH questionnaire. Therefore, these estimates may be somewhat inconsistent with drug estimates based on data collected from the "core" modules because NSDUH data are not edited for consistency across the "core" and "noncore" modules of the interview.
3 Estimates of Stimulant Needle Use, Methamphetamine Needle Use, and the Needle Use summary variable include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
HALLUCINOGENS 14.6 15.1 3.3a 2.8 17.6 17.6 15.4 16.2
PCP (Angel Dust, Phencyclidine) 2.5 2.5 0.4b 0.2 1.0 0.9 3.0 3.0
LSD (Acid) 9.1 9.4 1.0 0.9 5.9 6.5 10.7 11.0
Peyote 2.3 2.2 0.2 0.2 0.9 1.0 2.8 2.7
Mescaline 3.0 3.1 0.1 0.1 1.0 0.9 3.8 3.8
Psilocybin (Mushrooms) 8.1a 8.7 1.3 1.2 9.3 9.6 8.7a 9.5
Ecstasy (MDMA) 6.2a 6.8 2.0b 1.5 12.9 12.8 5.6b 6.4
INHALANTS 8.1 8.0 6.5b 5.3 8.4b 7.5 8.3 8.4
Amyl Nitrite, Poppers, Locker Room Odorizers, or Rush 2.6 2.8 0.9 0.7 1.4 1.5 3.0 3.3
Correction Fluid, Degreaser, or Cleaning Fluid 0.7 0.5 1.3 1.1 0.7 0.6 0.6 0.4
Gasoline or Lighter Fluid 1.3b 1.0 2.1b 1.6 1.3b 0.9 1.2 1.0
Glue, Shoe Polish, or Toluene 1.2 1.1 2.3a 1.9 1.1 1.0 1.1 1.0
Halothane, Ether, or Other Anesthetics 0.3 0.3 0.2 0.2 0.3 0.3 0.4 0.3
Lacquer Thinner or Other Paint Solvents 0.6 0.5 1.0b 0.7 0.6 0.5 0.6 0.5
Lighter Gases (Butane, Propane) 0.3 0.3 0.6a 0.4 0.3 0.3 0.3 0.3
Nitrous Oxide or Whippits 4.7 4.7 0.8 0.6 5.2b 4.4 5.1 5.3
Spray Paints 0.7 0.6 2.1b 1.4 0.9 0.8 0.5 0.5
Other Aerosol Sprays 0.8 0.8 1.3a 1.0 1.4 1.4 0.6 0.6
NEEDLE USE1,2,3 1.6 1.7 0.2 0.2 1.3 1.4 1.8 1.9
Heroin Needle Use1,2 0.8 1.0 0.1 0.1 0.8 0.9 0.9 1.1
Cocaine Needle Use1,2 0.8 0.9 0.0 0.0 0.4 0.5 0.9 1.0
Stimulant Needle Use1,2,3 0.7a 0.9 0.1 0.1 0.5 0.6 0.8a 1.1
Methamphetamine Needle Use1,2,3 0.6 0.7 0.0 0.1 0.4 0.4 0.7 0.9
HEROIN 1.8 1.8 0.2 0.2 1.9 1.8 1.9 2.0
Smoke Heroin2 0.7 0.6 0.1 0.1 0.9 0.8 0.7 0.7
Sniff or Snort Heroin2 1.3 1.2 0.1 0.1 1.4 1.3 1.4 1.4
140324
Table 1.89A – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Numbers in Thousands, 2012 and 2013
Pain Reliever Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Darvocet®, Darvon®, or Tylenol® with Codeine 18,079 16,907 837a 723 2,808b 2,465 14,435 13,719
Percocet®, Percodan®, or Tylox® 14,136 13,953 361a 288 3,012 2,822 10,763 10,843
Vicodin®, Lortab®, or Lorcet® 23,731a 22,315 850b 691 5,548b 4,950 17,332 16,673
Codeine 6,825 7,264 335 271 1,694 1,746 4,796 5,247
Demerol® 1,901 2,316 42 30 287 225 1,572a 2,060
Dilaudid® 1,762 1,730 12 17 334 342 1,417 1,371
Fioricet® 359 570 9 3 58 66 291 501
Fiorinal® 249 401 16 11 32 34 200 356
Hydrocodone 11,416 11,588 371 368 3,034 2,787 8,011 8,433
Methadone 2,460 2,488 98 66 737 680 1,625 1,742
Morphine 3,587 3,792 179 154 1,098 986 2,310 2,652
OxyContin® 6,579 6,973 322 274 2,011 1,889 4,247 4,811
Phenaphen® with Codeine 625 752 48 30 157 193 420 530
Propoxyphene 269 225 29 11 60 58 180 155
SK-65® 42 50 15 18 18 15 * 18
Stadol® 105 169 5 2 17 11 84 157
Talacen® 50 42 12 8 11 12 26 22
Talwin® 232 239 17 4 22 7 193 228
Talwin® NX 122 44 4 4 15 16 102 24
Tramadol 2,719 3,197 87 89 857 928 1,775 2,181
Ultram® 1,299 1,645 32 27 234 271 1,033 1,348
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 20,058 19,182 1,014a 888 3,463 3,290 15,581 15,004
Oxycodone Products3 16,027 15,997 562a 476 3,678 3,449 11,788 12,072
Hydrocodone Products4 25,675 24,413 1,014a 856 6,086b 5,538 18,575 18,019
Tramadol Products5 3,233a 3,786 101 105 914 983 2,218 2,699
140324
Table 1.89B – Nonmedical Use of Specific Pain Relievers in Lifetime, by Age Group: Percentages, 2012 and 2013
Pain Reliever Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Pain Relievers module but fall into this category.
2 Includes Darvocet®, Darvon® or Tylenol® with Codeine, codeine, Phenaphen® with Codeine, propoxyphene, and SK-65®.
3 Includes Percocet®, Percodan® or Tylox®, and OxyContin®.
4 Includes Vicodin®, Lortab®, or Lorcet®, and hydrocodone.
5 Includes tramadol and Ultram®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Darvocet®, Darvon®, or Tylenol® with Codeine 7.0a 6.4 3.4a 2.9 8.1b 7.1 7.2 6.8
Percocet®, Percodan®, or Tylox® 5.4 5.3 1.4a 1.2 8.7 8.1 5.4 5.3
Vicodin®, Lortab®, or Lorcet® 9.1a 8.5 3.4b 2.8 16.0b 14.2 8.6 8.2
Codeine 2.6 2.8 1.3 1.1 4.9 5.0 2.4 2.6
Demerol® 0.7 0.9 0.2 0.1 0.8 0.6 0.8a 1.0
Dilaudid® 0.7 0.7 0.0 0.1 1.0 1.0 0.7 0.7
Fioricet® 0.1 0.2 0.0 0.0 0.2 0.2 0.1 0.2
Fiorinal® 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.2
Hydrocodone 4.4 4.4 1.5 1.5 8.8a 8.0 4.0 4.2
Methadone 0.9 0.9 0.4 0.3 2.1 2.0 0.8 0.9
Morphine 1.4 1.4 0.7 0.6 3.2 2.8 1.2 1.3
OxyContin® 2.5 2.7 1.3 1.1 5.8 5.4 2.1 2.4
Phenaphen® with Codeine 0.2 0.3 0.2 0.1 0.5 0.6 0.2 0.3
Propoxyphene 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1
SK-65® 0.0 0.0 0.1 0.1 0.1 0.0 * 0.0
Stadol® 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1
Talacen® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Talwin® 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1
Talwin® NX 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Tramadol 1.0 1.2 0.4 0.4 2.5 2.7 0.9 1.1
Ultram® 0.5 0.6 0.1 0.1 0.7 0.8 0.5 0.7
SELECTED GROUPS OF DRUGS1                
Propoxyphene or Codeine Products2 7.7 7.3 4.1a 3.6 10.0 9.5 7.8 7.4
Oxycodone Products3 6.2 6.1 2.3a 1.9 10.6 9.9 5.9 6.0
Hydrocodone Products4 9.9a 9.3 4.1a 3.4 17.6b 15.9 9.3 8.9
Tramadol Products5 1.2 1.4 0.4 0.4 2.6 2.8 1.1 1.3
140324
Table 1.90A – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Numbers in Thousands, 2012 and 2013
Tranquilizer Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Klonopin® or Clonazepam 5,799 6,112 184 143 1,598 1,538 4,017 4,431
Xanax®, Alprazolam, Ativan®, or Lorazepam 15,613 15,529 517b 405 3,687 3,594 11,410 11,531
Valium® or Diazepam 13,045 12,471 221b 129 1,745 1,600 11,079 10,742
Atarax® 236 241 13 11 53 34 170 197
BuSpar® 732 570 20 14 167 155 545 401
Equanil® 55 87 7 3 18 24 30 61
Flexeril® 3,149 2,878 36 28 528 489 2,585 2,361
Librium® 695 638 12 10 57 56 626 571
Limbitrol® 62 38 11 9 21 13 31 16
Meprobamate 133 125 13 7 27 16 93 102
Miltown® 161 76 7 5 24 18 130 53
Rohypnol® 256 348 27 12 69 64 160 272
Serax® 53 62 7 2 25 14 21 45
Soma® 3,690 3,312 63 69 820 693 2,808 2,550
Tranxene® 113 73 5 4 18 15 90 53
Vistaril® 263 329 13 9 74 78 176 241
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 22,086 22,096 655b 498 4,249 4,043 17,182 17,555
Meprobamate Products3 268 234 20 11 45 41 203 183
Muscle Relaxants4 5,530 5,099 85 89 1,119a 954 4,326 4,055
140324
Table 1.90B – Nonmedical Use of Specific Tranquilizers in Lifetime, by Age Group: Percentages, 2012 and 2013
Tranquilizer Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Includes other-specify drug responses that are not asked about explicitly in the Tranquilizers module but fall into this category.
2 Includes Klonopin® or clonazepam, Xanax®, alprazolam, Ativan® or lorazepam, Valium® or diazepam, Librium®, Limbitrol®, Rohypnol®, Serax®, and Tranxene®.
3 Includes Equanil®, meprobamate, and Miltown®.
4 Includes Flexeril® and Soma®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Klonopin® or Clonazepam 2.2 2.3 0.7 0.6 4.6 4.4 2.0 2.2
Xanax®, Alprazolam, Ativan®, or Lorazepam 6.0 5.9 2.1b 1.6 10.7 10.3 5.7 5.7
Valium® or Diazepam 5.0 4.8 0.9b 0.5 5.0 4.6 5.5 5.3
Atarax® 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1
BuSpar® 0.3 0.2 0.1 0.1 0.5 0.4 0.3 0.2
Equanil® 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0
Flexeril® 1.2 1.1 0.1 0.1 1.5 1.4 1.3 1.2
Librium® 0.3 0.2 0.0 0.0 0.2 0.2 0.3 0.3
Limbitrol® 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Meprobamate 0.1 0.0 0.1 0.0 0.1 0.0 0.0 0.1
Miltown® 0.1 0.0 0.0 0.0 0.1 0.1 0.1 0.0
Rohypnol® 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1
Serax® 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Soma® 1.4 1.3 0.3 0.3 2.4 2.0 1.4 1.3
Tranxene® 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0
Vistaril® 0.1 0.1 0.1 0.0 0.2 0.2 0.1 0.1
SELECTED GROUPS OF DRUGS1                
Benzodiazepines2 8.5 8.4 2.6b 2.0 12.3 11.6 8.6 8.7
Meprobamate Products3 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1
Muscle Relaxants4 2.1 1.9 0.3 0.4 3.2a 2.7 2.2 2.0
140324
Table 1.91A – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Numbers in Thousands, 2012 and 2013
Stimulant Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Methamphetamine, Desoxyn®, or Methedrine1 12,259 12,257 145 119 1,089 1,042 11,025 11,096
Prescription Diet Pills2 7,246 7,175 125 94 729a 594 6,391 6,487
Ritalin® or Methylphenidate 6,008 6,397 242 217 1,790 1,824 3,976 4,355
Cylert® 112 147 8 8 22 16 82 124
Dexedrine® 1,689 1,922 14 11 100 69 1,575 1,841
Dextroamphetamine 770 993 18 31 193 166 558 796
Didrex® 97 76 3 3 9 22 85 51
Eskatrol® 148 86 6 3 14 15 128 69
Ionamin® 300 313 4 9 3 11 294 294
Mazanor® 38 16 10 3 11 3 17 11
Obedrin-LA® 20 15 5 3 * 9 14 *
Plegine® 26 27 5 5 6 3 15 19
Preludin® 335 223 6 * 19 14 310 210
Sanorex® 40 * 14a 2 6 5 20 *
Tenuate® 100 99 2 4 10 8 88 86
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 9,400 9,819 232 199 1,519 1,467 7,650 8,153
Mazindol Products5 74b 22 22a 4 15 7 37 11
Methylphenidate or Dexmethylphenidate Products6 6,050 6,447 245 224 1,816 1,853 3,990 4,370
140324
Table 1.91B – Nonmedical Use of Specific Stimulants in Lifetime, by Age Group: Percentages, 2012 and 2013
Stimulant Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Also known as crank, crystal, ice, or speed. Estimates of Use of Methamphetamine, Desoxyn®, or Methedrine include data from new methamphetamine items added in 2005 and 2006 and are not comparable with estimates presented in NSDUH reports prior to the 2007 National Findings report. See Section B.4.8 in Appendix B of the Results from the 2008 National Survey on Drug Use and Health: National Findings.
2 Respondents were asked about their use of prescription diet pills and were given the following as examples: amphetamines, Benzedrine®, Biphetamine®, Fastin®, or phentermine. However, respondents were not given an exhaustive list of examples of prescription diet pills.
3 Includes other-specify drug responses that are not asked about explicitly in the Stimulants module but fall into this category.
4 Includes prescription diet pills, Dexedrine®, dextroamphetamine, and Ionamin®.
5 Includes Mazanor® and Sanorex®.
6 Includes Ritalin®, other products containing methylphenidate, and products containing dexmethylphenidate.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Methamphetamine, Desoxyn®, or Methedrine1 4.7 4.7 0.6 0.5 3.1 3.0 5.5 5.5
Prescription Diet Pills2 2.8 2.7 0.5 0.4 2.1a 1.7 3.2 3.2
Ritalin® or Methylphenidate 2.3 2.4 1.0 0.9 5.2 5.2 2.0 2.1
Cylert® 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1
Dexedrine® 0.6 0.7 0.1 0.0 0.3 0.2 0.8 0.9
Dextroamphetamine 0.3 0.4 0.1 0.1 0.6 0.5 0.3 0.4
Didrex® 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0
Eskatrol® 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Ionamin® 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1
Mazanor® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Obedrin-LA® 0.0 0.0 0.0 0.0 * 0.0 0.0 *
Plegine® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Preludin® 0.1 0.1 0.0 * 0.1 0.0 0.2 0.1
Sanorex® 0.0 * 0.1a 0.0 0.0 0.0 0.0 *
Tenuate® 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
SELECTED GROUPS OF DRUGS3                
Amphetamine, Dextroamphetamine, and Phentermine Products4 3.6 3.7 0.9 0.8 4.4 4.2 3.8 4.0
Mazindol Products5 0.0b 0.0 0.1a 0.0 0.0 0.0 0.0 0.0
Methylphenidate or Dexmethylphenidate Products6 2.3 2.5 1.0 0.9 5.2 5.3 2.0 2.2
140324
Table 1.92A – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Numbers in Thousands, 2012 and 2013
Sedative Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Methaqualone, Sopor®, or Quaalude® 5,159 4,811 24 21 56 80 5,079 4,710
Barbiturates1 2,069 1,979 24 11 37a 75 2,008 1,892
Restoril® or Temazepam 1,246 910 58a 31 140 143 1,047 737
Amytal® 120 125 10 7 10 22 100 96
Butisol® 164 26 6 4 16 9 142 13
Chloral Hydrate 92 99 7 5 14 10 72 84
Dalmane® 164 251 9 4 19 16 136 230
Halcion® 435 459 10 8 22 29 404 422
Phenobarbital 835 848 22 16 30a 71 784 762
Placidyl® 660 542 4 3 5 7 651 532
Tuinal® 724 701 3 5 9 4 712 691
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 1,686 1,436 69a 42 161 170 1,455 1,225
Any Barbiturates4 2,627 2,466 58 38 78 126 2,491 2,303
140324
Table 1.92B – Nonmedical Use of Specific Sedatives in Lifetime, by Age Group: Percentages, 2012 and 2013
Sedative Total
(2012)
Total
(2013)
Aged 12-17
(2012)
Aged 12-17
(2013)
Aged 18-25
(2012)
Aged 18-25
(2013)
Aged 26+
(2012)
Aged 26+
(2013)
*Low precision; no estimate reported.
a Difference between estimate and 2013 estimate is statistically significant at the 0.05 level.
b Difference between estimate and 2013 estimate is statistically significant at the 0.01 level.
1 Respondents were asked about their use of barbiturates and were given the following as examples: Nembutal®, pentobarbital, Seconal®, secobarbital, or butalbital. However, respondents were not given an exhaustive list of examples of barbiturates.
2 Includes other-specify drug responses that are not asked about explicitly in the Sedatives module but fall into this category.
3
Includes Restoril®, temazepam, Dalmane®, or Halcion®.
4 Includes barbiturates, Amytal®, Butisol®, phenobarbital, and Tuinal®.
Source: SAMHSA, Center for Behavioral Health Statistics and Quality, National Survey on Drug Use and Health, 2012 and 2013.
Methaqualone, Sopor®, or Quaalude® 2.0 1.8 0.1 0.1 0.2 0.2 2.5 2.3
Barbiturates1 0.8 0.8 0.1 0.0 0.1a 0.2 1.0 0.9
Restoril® or Temazepam 0.5 0.3 0.2a 0.1 0.4 0.4 0.5 0.4
Amytal® 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0
Butisol® 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0
Chloral Hydrate 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
Dalmane® 0.1 0.1 0.0 0.0 0.1 0.0 0.1 0.1
Halcion® 0.2 0.2 0.0 0.0 0.1 0.1 0.2 0.2
Phenobarbital 0.3 0.3 0.1 0.1 0.1a 0.2 0.4 0.4
Placidyl® 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.3
Tuinal® 0.3 0.3 0.0 0.0 0.0 0.0 0.4 0.3
SELECTED GROUPS OF DRUGS2                
Temazepam, Flurazepam, or Triazolam3 0.6 0.5 0.3a 0.2 0.5 0.5 0.7 0.6
Any Barbiturates4 1.0 0.9 0.2 0.2 0.2 0.4 1.2 1.1

Go to Top of PageGo to the Table of Contents